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1.1 The importance of hair and nail concentrations of psychoactive substances in 
forensic toxicology  
Over the last thirty years, the retrospective detection of xenobiotics in hair has found its own 
valuable place in the work of forensic toxicologists. To date, numerous applications of hair analysis 
are performed in forensic laboratories all over the world. They can include aspects  such as the 
human performance (workplace drug testing, abstinence control, doping control), the diagnosis of 
a recent drug abuse or chronic intoxication (drug abuse history, exposure to drugs during 
pregnancy, toxic environmental pollution), criminal liability and drug addiction, or the wide field of 
post mortem toxicology (health impairment or tolerance effects from chronic drug abuse, body 
identification, pattern of drug abuse, proof or exclusion of a drug administration, repeated criminal 
poisoning) [1].  On the other hand, hair analysis can be used in criminal assaults (single or 
repeated drug administration, control of regular intake by the offender), therapy adherence control 
(segmental hair analysis) or in the detection of excessive alcohol abuse [1].   
Considerable research attention has been devoted to gain insight in the possibilities of the analysis 
of human hair. Several scientific reviews have described the useful advantages of hair as matrix 
for the detection of xenobiotics [2-7]. Compared to body fluids (e.g. blood, urine) it allows for a 
wider detection window after drug exposure while sampling itself is non-invasive and discrete [2]. 
Preferably, the hair is sampled from the scalp, as most of the research is conducted with scalp 
hair. If scalp hair is not available (e.g. from reduced hair growth or haircut), body hair from different 
body sites (e.g. beard, arm, leg, breast, pubic area) can be used under certain limitations for 
interpretation.   
Today, toxicologists are not only able to detect and quantify a high number of substances in human 
hair, they are also in the position to make valid interpretations of these results. Tools like the 
segmental analysis or the detection of metabolites have demonstrated their value to achieve even 
better interpretations of the analytical results. 
Until now, the vast majority of research in hair analysis has focused on the detection of drugs of 
abuse and markers of alcohol consumption. Based on this profound knowledge scientific 
communities like the Society of Hair Testing (SoHT) have been able to recommend cut-off values 
for a high number of illegal drugs [8]. In addition, metabolite-parent drug ratios have been 
proposed to discriminate between an actual drug use or a contamination [8, 9].  
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Due to their sedative properties [10, 11], their relatively high toxicity [12] and their broad 
prescription frequency [13], psychotropic drugs (antidepressants, antipsychotics) can often be part 
of certain forensic case constellations. Only few studies reported the examination of the detection 
of drugs like antidepressants, antipsychotics or sedatives. Approaches for a qualitive library-based 
identification of xenobiotics in different matrices have shown to be applicable for the detection of 
these substances [14]. Yet, the identification alone does not allow to make assumptions about the 
frequency of intake. Quantitative data, established from the analysis of a population with known 
intake, can be used for comparison and better interpretation of the frequency of use. Therefore, 
the examination of quantitative data on this group of substances is an important area of enquiry. 
A broad base of quantitative data of these substances is crucial to properly investigate certain 
case constellations. An example is given to illustrate the complexity of such constellations. 
A young child was found dead at home. Autopsy revealed unambiguous signs of an intoxication 
while the toxicologic examinations proved an intoxication with tricyclic antidepressants. The 
question arises if the antidepressants were stored close to the child and the child accidentally took 
them. On the other, the antidepressants may have been intentionally used to sedate the child. 
Hair analysis may give a rough guidance to the frequency of exposure over a longer time before 
death. This may point to a systematic sedation over time and provide valuable information for the 
investigation.     
The reality for most of forensic toxicologist is different. First, very few laboratories are able to 
quantify these substances in hair. Second, the available data is scarce since the scientific literature 
in this field is often limited to the presentation of case reports or investigations on small case 
numbers. A comparison with reference data or data from systematic studies is hardly possible and 
therefore interpretation of such results is difficult.  
For the purpose of further illustration, this scenario is extended by an additional aspect: 
An older brother of the child died 3 years ago without suspicion raised by the authorities. It was 
assumed to be a natural death by that time. An exhumation of the body may enable a toxicological 
investigation of organ tissue which reveals high levels of the same tricyclic antidepressant that 
was found in the younger sibling. Due to prolonged process of decay no hair is available for the 
investigation of a repeated administration before death. Only fingernails were still available for 
toxicological investigations.  
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The analysis of nails is even less well-investigated concerning psychotropic drugs and the 
toxicologist ends up with very difficult interpretation of the case. 
Another example is given to illustrate further constellations of forensic value: 
A woman went to the police with symptoms of dizziness and sedation and files a report of sexual 
abuse against her boyfriend. She states that she was sedated by him. A blood sample is taken at 
the hospital and screened for pharmaceutical drugs and drugs of abuse. The analysis reveals an 
acute influence of benzodiazepines. Asked by the police, the boyfriend states that he never 
sedated his girlfriend, nor did he know about benzodiazepines. A prescription for the 
benzodiazepine bromazepam is found in the home of the woman. The polices orders the analysis 
of a hair sample of both persons. In the hair sample of the man, no benzodiazepines were found. 
The woman was tested with high levels of bromazepam which was interpreted as frequent use in 
the months before the incident.   
Again, the hair analysis is crucial for the outcome of the investigation of the case but data on 
bromazepam concentrations in hair is scarce.  
In all constructed cases it is difficult to do well-founded interpretation without quantitative data. On 
the other hand, the cases may be interpreted differently and maybe not in the favor of the victims 
if a hair analysis is not done.  
Out of this conflict and difficulties in daily forensic work the main ideas and objectives for this 
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1.2 Aims and objectives  
Today's routine forensic work in hair analysis is mainly concerned with the investigation of alcohol 
markers and narcotics, for which a high level of experience has been gained over the last 30 
years. However, the number of requests for the investigation of active pharmaceutical ingredients 
and psychotropic drugs is increasing rapidly. Case constellations such as those described above 
can occur at any time and confront the forensic scientist with challenging interpretations. The main 
objective of this thesis is therefore to meaningfully expand the current data situation regarding the 
detection of psychotropic drugs (antidepressants and antipsychotics) in hair in order to enable a 
comprehensive interpretation of such hair findings in daily forensic work.  
Controlled dose studies in which volunteers take a defined amount of substances and then have 
their hair examined would be the best approach to obtain meaningful data. From an ethical point 
of view, however, such studies must be weighed very carefully. This calls for a search for alternate 
ways to enable research on this topic. In postmortem investigations, hair is routinely preserved 
and is available for research purposes. However, the significance of such investigations is 
somewhat limited, as it is not possible to estimate with reasonable certainty which dose was taken 
in the period before death. Nevertheless, the data can be assessed in retrospective studies, offers 
a good orientation and is ethically safer to obtain. In postmortem case investigation there is hardly 
valid information on the prescribed medication of the deceased. On the other hand, preparation 
and extraction of hair samples is a time consuming and intensive effort. In order not to waste time 
and money on negative hair samples an effective selection of suitable cases is crucial. Therefore, 
an observational study should be conducted to identify postmortem cases from the Institute of 
Legal Medicine and Forensic Sciences with a possible intake of antidepressants or antipsychotics 
prior to death. It was assumed that these deceased could have taken these substances of a longer 
period of time. These cases were to be included in a second study where the available hair 
samples were analyzed for antidepressants, antipsychotics and benzodiazepines in hair. 
Therefore, another aim of this work was the development of a fast and robust liquid 
chromatography–tandem mass spectrometry (LC-MS/MS) method for the detection and 
quantification of antidepressants, antipsychotics and benzodiazepines in human hair. This method 
was then validated according to guidelines of the German Society of Toxicological and Forensic 
Chemistry (GTFCh) [15] to ensure the quality of the obtained results. For an adequate statistical 
representation of the missing dose information, the data should be presented in percentiles, as 
also applied by Musshoff et al. [16] and Tsanaclis et al. [17] as effective. The presentation in 
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percentiles should be able to represent the variations within the investigated purposes, hair 
lengths and populations well. 
A work by Krumbiegel et al. [18] revealed that nails and hair showed comparable results in 
screening tests and thus nails became the focus of attention as an alternative matrix to hair. Thus, 
it was aimed to develop and validate [15] LC-MS/MS methods for the determination of alcohol 
markers, narcotics and psychotropic drugs in nails and hair and use them for an investigation on 
incorporation mechanisms and the comparability of the two matrices. Therefore, hair and nail 
samples from postmortem case of the Institute of Legal Medicine and Forensic Sciences were to 
be investigated. A segmental analysis of both, hair and nails were to be conducted for the study 
of further insights on the incorporation pathways into the nail. The comparability of quantitative 
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2 Background 
2.1 Hair analysis between expectations and limitations 
2.1.1 Life cycle and structure of human hair 
The complex structure of human hair is reflected in its anatomy, physiology and its chemical 
properties which will be discussed in the following chapters. The visible part above the skin is the 
hair shaft, a heterogenous fiber formed of tightly glued keratinized cells [19]. Three concentric 
structures with different functions build the fiber from the outside to the inside: the cuticle, cortex 
and medulla (Figure 1a, [1]). The cuticle is a protective layer that anchors the hair shaft in the 
follicle and consists of a single layer of overlapping elongated cells [19]. Chemicals, heat, 
ultraviolet (UV) light, or mechanical stress can damage the protective layer which often results in 
a loss of cuticle cells towards the distal end of the shaft [19] (also known as “split ends”). The next 
inner layer, the cortex, represents the major content of the hair shaft and contains long keratinized 
cortical cells which are formed into fibers [19]. A special effect supports the strong tightness of this 
layer. During growth, small spaces between the cells are filled with a fluid that dries out when the 
hair grows out [19]. These small spaces, called fusi, are filled with air which works as kind of 
chemical cement and glues the cells together [19]. Melanin granules, pigments that give the hair 
color, are mainly located in the cortical cells [19] and partly in the cuticle cells [5]. Finally, the 
innermost layer, the medulla, consists of loosely packed medullar cells that dehydrate, shrivel and 
then leave small vacuoles along the shaft. Only a small percentage of medullar cells is found in 
human hair while they may also be completely absent or discontinuous along the center of the 
hair shaft [19].  




Figure 1 - overview of a human hair shaft (a), overview of a hair follice (b), overview of the cell 
types in the basement membrane (c), taken from Pragst et al. [1] 
 
Hair follicles are sac-like organs at the root of the hair and place of growth of a hair [19]. Located 
in the epidermis of human skin they are embedded approximately 3-4 mm below the surface [19]. 
Figure 1b gives an overview of the structure of the follicle. Harkey describes three functional zones 
along the axis of the hair [19]: an innermost zone, containing the basement membrane in and 
around the bulb on the basement of the follicle. The basement membrane contains keratinocytes 
and melanocytes [1] that divide, increase in volume, and elongate [19]. From this germination 
center, which is located around the hair bulb papilla, the rapid mitosis [1] forces the cells to move 
up along the axis into the keratogenous zone [19]. Here, genes for the formation of keratine are 
expressed and cell differentiation for the cortex and cuticle occurs [1]. While cortex cells change 
into a spindle-like form, cuticle cells change into a shingle-like structure [1]. Further up the shaft, 
the zone of hardening, disulfide bonding, resorption and dehydration is characterized by a loss of 
all cytoplasmatic content (cell nucleus and water release) [1, 19]. The cell membrane complex [1], 
a dense “horny” mass of coalesced cells is formed [19]. It consists of proteins and protein-lipid 
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complexes from previous cell membranes and is assumed to be site of deposition for lipophilic 
drugs [1]. In addition, it serves as the main diffusion point for the incorporation and elimination of 
drugs into hair [1]. The next zone is characterized by fully mature hair. Overall, the follicle is 
embedded in a rich capillary system that ensures supply with nourishment during the hair 
growth [19]. This connection to the blood stream is also mainly important for the incorporation of 
basic drugs [19] into hair. 
The sebaceous and apocrine glands are not only closely located to the follicle but are also 
functionally associated [19]. In most parts of the body, these glands and the follicles build 
functional fusions known as the pilosebaceous unit. In this unit, glands and follicles are so close 
to another that the ducts of both glands empty into the follicle. A third type of gland, the sweat 
gland, is located near the follicle [19]. All glands serve a different purpose: the sebaceous gland 
produces sebum, a waxy lipophilic substance, that covers the hair shaft before it emerges out of 
the skin [19]. Apocrine glands also cover the hair shaft with an oily, colorless and odorless 
substance yet its functions are still not fully understood. The apocrine glands are only expressed 
in the armpits and intimate sites [1, 19]. Sweat produced in the sweat gland moistures the hair 
shaft and can be a vehicle for the incorporation of hydrophilic drugs [1].  
The basement membrane contains melanocytes and keratinocytes closely together (Figure 1c) in 
a ratio of about 1:5 [1]. Melanin pigments are produced in melanosomes within the melanocytes. 
Melanin granules or hair pigments were already mentioned as being responsible for the hair color. 
Trough long dendrites the melanocytes transport these melanosomes to neighboring 
keratinocytes where the melanin pigments are phagocytized and then imbedded in the 
keratinocytes [1]. The composition (amount, distribution, type) of these melanin pigments finally 
defines the color the hair [19]. 
It is widely accepted that hair grows in a cyclical process, which is regulated by the activity of 
cytokines (hormones) [20]. The cycle is characterized by three stages: the anagen phase (growth 
phase), the catagen phase (transitional phase) and the telogen phase (resting phase) [20]. During 
the anagen phase, the phase of active growth, cells in the bulb (root) are rapidly divided. A thin 
filament is built out of the elongation of these cells [3] followed by an upward movement of the 
cells into the follicular canal. There, the cells differentiate into different cell types of the cuticle, 
cortex or the medulla and begin to keratinize. This phase can last for several years [1, 5, 21]. After 
the anagen phase, the hair enters a transitional phase, the catagen phase, which lasts about 2-3 
weeks [3, 1]. The hair shaft becomes fully keratinized, the cell division stops and the bulb begins 
to degenerate during this phase [5]. The third phase or resting phase (telogen phase) is 
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characterized by a complete stop of hair growth while the hair shaft retains in the upper follicular 
canal [19]. It is then easily removed from the scalp by pulling. For scalp hair this resting phase is 
up to 10 weeks long [19]. Hair from other body sites can remain in the telogen phase for 2-6 years 
[19]. The existing literature emphasizes that hair follicles grow individually and not synchronous 
[19]. The amount of hair in the growing stage or in the resting stage differs for hair from different 
body sites [19]. Previous research has supported the hypothesis that a proportion of approximately 
85 % of the adult scalp hair is in the anagen phase while the remaining 15 % are in the resting 
phase [19, 21]. 
A number of scientists have turned their attention to the growth rates of hair from different body 
sites [1, 5]. The review of this literature showed a general growth rate of 0.6 cm - 1.4 cm per month 
for scalp hair [1, 5]. A recommendation by the SoHT proposes the estimation of an average growth 
rate of 1 cm per month [8]. However, Kintz et al. [5] pointed out that this might be an 
oversimplification since there was also a publication that found a maximum growth rate of 3.36 cm 
per month [22]. In addition, the growth rate depends on the type of hair, the body location and age 
of the person [6]. A lack of published information on growth rates for children and teenagers was 
identified [5]. The hair growth of infants is driven by complex changes during pregnancy and is 
therefore even more difficult to interpret. Finally, it is estimated that the growing hair needs 
approximately 7-10 days to reach the head surface [5]. Therefore, the proximal end of a cut hair 
strand (cut close to the scalp) does not represent the most recent period of hair growth [5]. Hair 
from the scalp is the hair of choice with the fastest growth rate and the highest proportion of hair 
in the anagen phase [5]. Significantly different growth rates and proportions of anagen/telogen 
phase have been reported for different body sites [8] which is considerable due to the mentioned 
variations. For example, leg hair grows about 0.6 cm per month [23]. Pubic hair and beard hair 
grow slower and have a higher proportion of telogen hair which leads to a longer detection window. 
However, pubic hair is prone to be contaminated by urine [5].  
Regarding the cyclic growth and the different growth rate, the window of detection needs careful 
interpretation with respect to the type of hair the body location of the hair sample. If a hair strand 
of 6 cm proximal scalp hair is analyzed, it should represent the last six months before sampling 
(assuming an average growth rate of 1 cm/month). In this hair strand there is about 15 % hair in 
the telogen phase. Thus, this hair has stopped growth sometime before the last six months. This 
hair then reflects a different time window than the 85 % anagen hair in this 6 cm hair strand. 
Therefore, the analyzed hair strand of 6 cm reflects the last six up to twelve months before 
sampling due to the telogen hair. That effect can be reduced if the head is fully shaven and only 
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the newly grown hair is used for an analysis after a defined growth period. For interpretation, it is 
advised to apply the respective growth rates for scalp and body to achieve a more precise time 
window of the analyzed hair length.  
2.1.2 Incorporation of xenobiotics in hair 
Over the last years an enormous amount of research has been conducted to study the mechanism 
of incorporation of xenobiotics into hair. Different models of incorporation have been described 
but still there is uncertainty about the precise mechanisms [1]. One of the basic assumptions, that 
substances follow a passive diffusion from the blood capillaries into the growing cells of the 
keratinization zone, failed to withstand experimental data [24-26] that indicated a more complex 
mechanism of incorporation [1]. Henderson et al. [27] proposed a multi-compartment model that 
is widely used in several books and scientific reviews [1, 3, 5, 28]. According to their model, 
incorporation occurs from blood during formation of hair, from sweat and sebum after formation 
and from the external environment after formation and the appearance of hair out of the skin [27]. 
Alternatively, an intradermal transfer of highly lipophilic drugs (e.g. tetrahydrocannabinol) [29] 
through several skin layers or binding of drugs to melanin-rich compartments is discussed [27]. It 
is still unclear which route of incorporation contributes to which extent, but it varies from drug to 
drug [5]. Pragst et al. [1] outlined that the chemistry of the substances itself is of great influence 
on the incorporation. On one hand there is the basicity and lipophilicity (lipophilic uncharged 
organic molecules are diffusion driven) of the substance itself and on the other hand the melanin 
content of the hair sample [1]. In addition to the general melanin-affinity of basic drugs [30, 31], 
the intracellular pH in keratinocytes [32] and melanocytes [30, 33] is in the acidic range. This leads 
to an accumulation of lipophilic and basic drugs in matrix cells [1]. Several studies investigating 
human and animal hair have found a correlation between the melanin concentration, which is 
correlated with the pigmentation, and incorporation of basic drugs into hair [33-37]. The 
incorporation of neutral compounds on the other hand has been found to be unaffected by 
pigmentation [35]. Acidic drugs however, like the metabolites of valproic acid or THC (11-nor-∆9-
tetrahydrocannabinol-11-carboxylic acid) are only incorporated in low concentration into the acidic 
matrix cells [1, 38]. Due to the gain of hydrophilicity during drug metabolism, metabolites are found 
in lower concentrations than their respective precursors [1, 39]. Once incorporated, most drugs 
are quite stable. Their stability depends on the chemical structure and increases with increasing 
polarity [1]. That leads to slower elimination of polar metabolites compared to their parent drugs 
[1]. In summary, basic drugs are consequently found in higher concentrations compared to neutral 
or acidic and lipophilic drugs [5]. 
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2.1.3 Influence of cosmetic treatment on hair analysis 
A widely accepted hypothesis is that drug concentration in hair can be altered after incorporation 
by different cosmetic treatments [1]. Aggressive oxidative bleaching or permanent wave can lead 
to an extensive decrease of the original drug concentration [1]. A report from Cirimele et al. [40] 
presented results from a person with separately treated hair (bleaching with hydrogen peroxide) 
and found up to 80 % higher drug concentrations of opiates in the unbleached hair compared to 
the bleached hair. This decrease of drug concentration by bleaching was demonstrated for 
cannabinoids as well [41]. In general, these aggressive treatments use strong basic solutions that 
damage the hair structure on different levels [3]. Bleaching as an oxidative-alkaline treatment with 
hydrogen-peroxide leads to a degradation of melanin granule by cleavage of the disulfide bonds 
and finally the decoloration of solubilized pigments [42]. The destruction of melanin results in a 
loss of binding sites for drug molecules in bleached hair and consequently the incorporation rate 
and drug concentration decreases [41, 42]. Hydrogen-peroxide is also capable of directly 
degrading the small drug molecules [42]. Perming or permanent wave disrupts keratinous disulfide 
bonds that are reconstructed in the hair matrix [3, 42]. Besides the mentioned reaction of hydrogen 
peroxide reactions to melanin pigments the hair cuticle is opened and the cortex of the hair swells 
when using a permanent dye [42]. Colorless precursor molecules in the dyeing preparation react 
with hydrogen peroxide in order to establish a new color [42].   
Also, “natural” factors like sunlight and weather conditions have been found to impact the drug 
concentration in hair [43]. Individual drug stability as well as the intensity of UV light and contact 
to water were identified as influencing factors [43, 44]. 
Further empirical work confirmed the degrading effect on drug concentrations under cosmetic 
treatment for several analytes although some analytes were assumed more stable to cosmetic 
treatment than others [45, 46]. Alcohol consumption biomarkers in hair however are especially 
prone to concentration alteration by cosmetic treatments [5]. A comprehensive study by Suesse 
et al. [47] investigated the effects of cosmetic treatment on the markers for excessive alcohol 
abuse ethylglucuronide (EtG) and fatty acid ethyl esters (FAEE). EtG showed a strong 
concentration decrease through bleaching, perming, and dyeing [47-49]. Thermal straightening 
also degrades the content of EtG in hair [50]. Ethanol in cosmetic products like hair spray on the 
other hand did not lead to false-positive results [47] since EtG is only formed in the liver. On the 
other hand, a few EtG containing commercial herbal hair products were identified that produced 
false-positive results after continuous application [51-53]. EtG is formed during ethanolic 
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extraction of plants in such products [53]. For the other alcohol marker FAEE different effects of 
cosmetic treatment were demonstrated [47]. Bleaching, dyeing and perming did not lead to a 
strong degradation [54] while ethanol containing hair products (wax, spray) led to an increase of 
FAEE concentration in hair [47, 54, 55]. The proposed mechanism is a diffusion of the topically 
applied ethanol into the sebum glands where it is metabolized to FAEE and then incorporated into 
the hair [54].  
The ongoing research on the effects of cosmetic treatment led to consequences for the practical 
applications of hair analysis. It is recommended that the past cosmetic treatment should be 
assessed prior to sampling [8]. For examinations in the context of drugs in driving in Germany 
cosmetically treated hair must not be used for a proof of abstinence from alcohol [56]. In that case, 
leg, beard or breast hair may be analyzed while the use of pubic or axillary hair is not allowed due 
to a possible contamination and sweat-related washout effects [56]. For drugs of abuse a treated 
hair sample may be analyzed if a second analysis of 6 cm untreated hair is directly followed [56]. 
However, investigators should be aware that the use of aggressive hair treatment is possible tool 
of manipulation [5]. In other contexts, like postmortem hair analysis, information on past hair 
cosmetic use is rare and investigators should consider these consequences in their interpretation 
of results. 
2.2 Nail analysis as an alternative to hair analysis 
Over the past 30 years, the analysis of hair has become established and intensively researched 
for retrospective substance detection in many fields of application in forensic toxicology. 
Nevertheless, there are some situations where hair is not available for investigation. Due to 
genetic predisposition or disease, there may be very little hair growth. In some cases, aggressive 
hair cosmetics also prevent adequate hair analysis, or the hair has been deliberately shaved off. 
In the context of postmortem toxicology, hair cannot be collected in some cases due to severe 
rotting, mummification or in burned bodies. Nails, which also consist of keratinized cells, have 
been discussed as a possible alternative matrix for retrospective substance detection [57] over 
the past years. The examination of nails became known for the first time for the detection of arsenic 
poisoning or other heavy metal exposure [58-59]. In 1984, the detection of methamphetamine in 
nail was the first report for the detection of drugs of abuse [60]. A study by Krumbiegel et al. [18] 
revealed that qualitative screenings in matched hair and nail analyses led to comparable results. 
To date, the main applications of nail analysis have been long-term monitoring of drug and alcohol 
abuse, workplace drug testing, drug adherence monitoring, drug-facilitated crimes (DFC), 
detection of prenatal drug exposure and postmortem toxicology [61]. 
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2.2.1 Anatomy, physiology and formation of nails 
Nails are located at the tips of the fingers and toes and have two functions: protection and the 
enhancement of the sense of touch [62]. A nail is categorized into six different parts illustrated in 
Figure 2: germinal matrix or nail root, lunula, nail bed, hyponychium, nail plate and nail folds [63]. 
The nail is formed in the nail root by the keratin cells in the germinal matrix, which lies under the 
skin and is protected by the proximal nail fold [64]. During the formation of new keratin cells, the 
old ones are pushed out through the cuticle and undergo a cytoplasmic condensation which results 
in the formation of the nail plate [64]. This formation goes in two directions: forward and upward. 
Thus, growth takes place not only in length but also in height. The length of the nail root determines 
the shape of the nail:  the longer the matrix, the more cells can be produced and the thicker the 
nail plate becomes [64]. Tightly knitted and interlocked dead keratinous cells build the nail plate 
which is approximately 0.5 mm thick. Also, the presence of only a few melanocytes in the germinal 
matrix leads to a lack of pigmentation of the nail [64]. 
 
Figure 2 - anatomy of a human nail, reprinted with permission from Garside et al. [64] 
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It is assumed that the nail plate is thinner at the free edge than the plate over the nail bed [65]. 
The nail bed is a flat, blood vessel rich surface that adheres the nail plate. It extends from the 
lunula to the hyponychium, which forms the transition between the nail bed and the normal 
epidermis.  
Unlike hair, nails do not grow in cycles [64]. Fingernails and toenails differ in their growth rate. The 
average growth rate of fingernails is 0.1 mm per day (3 mm per month) in contrast to 0.03 mm - 
0.04 mm per day for toenails [66, 67]. The complete replacement of a new fingernail takes about 
6 months while it takes about 12-18 months to replace a toenail due to the one third slower growth 
of the toenails [64]. In addition, growth depends on many individual differences such as gender, 
age and state of health. It is assumed that nails are formed 80 % in the germinal matrix and 20 % 
during growth via the nail bed [64]. The second growth process mainly contributes to the growth 
of thickness and occurs through the formation of ventral layers during growth from the lunula to 
the free nail end [65, 68]. 
2.2.2 Incorporation of xenobiotics into nails 
The incorporation of substances into the nail has so far only been clarified to a limited extent. The 
described ventral thickness growth contributes to a large extent to the kinetics of the deposition of 
substances in the nail, since the connection to the capillaries in the nail bed provides a large-area 
access over the entire nail [64]. From these capillaries a diffusion of the substances into the nail 
can take place, both during growth in the germinal matrix of the nail root and via the nail bed [57]. 
If the growth only passed through the germinal matrix, it could be assumed that a thin band of 
deposited substances would henceforth move from the lunula to the free end of the nail [62]. The 
detection of a substance in the edge of the nail would then prove an uptake about 3 - 5 months 
ago [57]. On the contrary, some studies have shown that the substances are detectable much 
earlier after an administration in the nail bed [62]. It was also shown that zolpidem, a sedative, 
was detectable in fingernails after a single oral dose very early [69]. Thus, three incorporation 
pathways were proposed [69]: a) contamination from sweat, detectable 24 h after administration, 
b) incorporation from the nail bed, detected after 2 weeks and c) incorporation from the growth in 
the germinal matrix, with a maximum level 3 months after the administration. Like hair, 
incorporation from an external source e.g. body fluids (sweat, sebum, saliva), powder or other 
substances can also occur in nails in the sense of contamination [57, 61]. The risk of an unintended 
external contamination seems to be greater for nails as touching of substances or body fluids can 
occur easily. It is still not well investigated to what extent a cosmetic treatment (e.g. acetone use 
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or polish) affects the concentration in the nail and should be clarified in the future to determine the 
suitability of nail clippings for abstinence control or the detection of long-term use [57]. 
In summary, the examination of nail clippings thus represents a time window of up to 5 months 
due to the growth and incorporation pathways in the nail [57, 69]. Due to the slower growth of the 
toenails, they represent a time window of about 8-14 months [57]. The concentration obtained 
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2.3 Chromatography and mass spectrometry in forensic toxicology 
2.3.1 Liquid chromatography with triple quadrupole mass spectrometry (LC-QQQ-MS) 
Mass spectrometry in general has become an integral part of forensic toxicology over the past 
decades. Many different devices with different techniques (gas chromatography with mass 
spectrometry (GC-MS), LC-QQQ-MS, liquid chromatography with time-of-flight mass 
spectrometry (LC-TOF-MS/LC-QTOF-MS) fit certain purposes within forensic laboratories. For the 
intended goal of presenting quantitative data on antidepressants and antipsychotics in hair, a 
LC-QQQ-MS device was used. This technique offers a wide range of linearity for the simultaneous 
quantification of very low concentrations and high concentrations. The analytes are dissolved in a 
liquid mobile phase which moves through a stationary phase (column) where the analytes are 
separated via interaction with the column material. After this separation, the mobile phase 
containing the mix of analytes is then transferred into the mass spectrometer where it is ionized 
via electrospray ionization (ESI). An electrical field is applied to transfer the mix of ions into the 
mass spectrometer where they are separated by their mass-to-charge ratio (m/z) using 
quadrupoles as mass analyzers [71]. The most sensitive and selective mode is the multiple 
reaction monitoring (MRM). In this setup the first quadrupole (Q1) is used as a mass filter, only 
letting ions of a specific m/z (precursor ions) pass into a second quadrupole or octopole unit (Q2). 
Here, the Q2 serves as a collision cell where the filtered ions collide with inert gas molecules into 
new fragment ions. This mix of fragment ions is further transferred into the third quadrupole (Q3) 
which is again used as mass filter, only letting ions of a predefined mass (product ions) pass into 
the detector to produce a signal. The combination of specific precursor ion selection and explicit 
product ion selection offers a very specific detection of the compound. For each analyte of interest, 
a fragmentation profile, also called MRM transition, can be detected simultaneously during an 
analytical run. A main disadvantage of this measurement is that only transitions that were 
predefined in the method are acquired. If there is new information and the toxicologist wants to 
detect another compound, a new measurement with the respective predefined MRM transition 
must be done. On the other hand, this approach is useful for the analysis of complex biological 
matrices since it does not scan the whole mass range nor detects co-eluting matrix components 
of a different mass. Usually the MRM transition (quantifier) with the highest abundance is used for 
quantification while the second or third most abundant transitions are used as qualifiers. The ratio 
of quantifier and qualifier as well as the retention time must be in a predefined range to confidently 
identify a substance for forensic purposes.  
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2.3.2 Method validation according to GTFCh guidelines 
Forensic laboratories must meet an extraordinary quality standard when their results are used for 
legal purposes. The used techniques need to be highly reliable, based on the current state of art 
and they must be “defendable” in court. Two instruments are now commonly used to ensure quality 
in forensic toxicological investigations: the norm DIN EN ISO/IEC 17025 [72] which regulates 
general requirements for the competence of testing and calibration laboratories and the guidelines 
for the validation analytical methods from the GTFCh [15, 73]. Although the foundation for the 
GTFCh guidelines is within the DIN ISO norm (e.g. personal qualifications, laboratory layout, 
laboratory safety, quality control samples) the focus will be on the validation guidelines for the 
purpose of this thesis. The guideline recommends validation parameters and their acceptance 
criteria together with the required statistical background and is based on current state of 
knowledge [15]. Several parameters must be tested and documented to show that an analytical 
method gives accurate, precise and robust results [15]:  
- Selectivity as the capability of the method to detect and identify substances unambiguously and 
without interferences from endogenous or exogenous substances and 
Specificity as the capability to detect a single substance without being affected by other 
substances in the sample 
In a series of blank samples from different batches, also spiked with an internal standard or other 
substances than the validated ones, no interfering peaks or signals should occur.  
- Linearity of calibration as the capability to produce a directly proportional relationship between 
the response and the concentration of a substance within a certain concentration range.  
The range of calibration should cover vast majority of expected concentrations and includes 
upper and lower concentrations for which acceptable precision, accuracy and linearity has been 
shown. Repeated measurement (six-fold) of the chosen calibrators (at least five) and 
subsequent plotting of the peak area ratios (substance/internal standard) allows further 
statistical testing. Outliers must be identified by the Grubbs-test (significance level 95 %). The 
homogeneity of variance is tested using the Cochran-test (significance level 99 %). If 
homoscedasticity is evident, a simple regression is used, and the fit is tested with the Mandel’s 
linearity test. In case of heteroskedasticity two options are possible: (a) limitation of the 
calibration range until homoscedasticity is reached or the application of a weighted calibration 
model (e.g. 1/x or 1/x²) for compensation of the heteroskedasticity. After application of the weight 
factors, the fit is again tested by the Mandel’s linearity test. 
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- Accuracy is measured as the difference between an individual result and a reference value that 
originates from systematic (bias) and random errors (precision) 
The repeated measurement of quality control samples with known concentrations on eight 
different days allows the statistical evaluation of the bias (acceptance criterion: bias ±15% and 
±20% near the limit of quantification). The precision expressed as the repeatability (acceptance 
criterion: relative standard deviation (RSD) ≤ 15 % and 20 % near the limit of quantification) and 
the intermediate precision (acceptance criterion: RSD ≤ 15 % and 20 % near the limit of 
quantification) are also tested with this approach. Furthermore, the accuracy is tested as the 
combination of bias and precision and expressed as the 95 % β tolerance interval (acceptance 
criterion: ±30% and ±40% near the limit of quantitation). 
- Stability as documentation that a substance is chemically stable in a prepared sample over a 
given time interval under certain conditions 
At least six measurements over a time window corresponding routine laboratory workaround are 
tested with a linear regression. Only the peak areas are used and the maximum acceptable 
decrease over the testing period is 25% (for deuterated standards) and 15% in other cases (20% 
near the limit of quantification).  
- Limit of detection as the lowest possible concentration to identify a substance 
Limit of quantification as the lowest concentration of a substance that can be measured with an 
acceptable bias (±20 %) and precision (RSD=20 %) 
Both parameters can be tested using the DIN ISO 32645 [74], where both limits are calculated 
based on at least five calibration levels near the expected limit of detection. 
- Matrix effects that lead to a suppression or enhancement of the ion abundance by the presence 
of a co-eluting substance  
Recovery as the complete transfer of the analyte into final extract after sample preparation 
In LC-MS/MS methods, the recovery and matrix effects can be tested together. At least five 
different spiked matrix samples, spiked matrix extract and neat standard solutions at different 
concentrations are compared. The recovery is calculated as the ratio of the peak areas of the 
spiked matrix samples to those of the corresponding spiked extracts (acceptance criterion: more 
than 50 %). The matric effect is expressed as the ratio of the peak areas of the 
spiked extracts to those of the neat standard solutions (acceptance criterion: 75-125 % and 
max. 25 % standard deviation when deuterated standards are used) 
All acceptance criteria and statistical tests (e.g. Grubbs Test, Mandel’s F Test) must be passed 
and documented for every analyte to fully validate a method.  




3.1 Manuscript Ⅰ 
Hair analysis of antidepressants and antipsychotics - Overview of quantitative data 
Reprinted with permission from Drug Testing and Analysis (Open Access, Creative Commons 
Attribution Non-Commercial No Derivatives License CC BY-NC-ND), Copyright (2020) The 
Authors. Drug Testing and Analysis published by John Wiley & Sons Ltd 
3.1.1 Summary 
Hair analysis is widely used today for various issues in the field of forensic toxicology, such as 
workplace testing, driving ability assessments, post-mortem toxicology, drug-related crimes, 
doping control, therapy compliance testing, evaluation of drug history or chronic intoxication and 
excessive alcohol consumption testing [1]. Because of their sedative properties [10, 11], their 
relatively high toxicity [12] and their broad prescription frequency [13], psychotropic drugs 
(antidepressants, antipsychotics) are often part of these questions. According to Pragst [75], the 
biggest pitfall for such investigations lies in the interpretation of the results and not in the actual 
execution of hair analyses. This requires a critical examination of the basics of hair analysis, but 
also an understanding of how the tested substances are incorporated into the hair. The aim of the 
present publication was therefore to show the extent to which psychotropic drugs have been 
researched in hair and at the same time to help colleagues in forensic toxicology to interpret their 
own cases with the comparative presentation of quantitative hair concentrations. 
A comprehensive literature search revealed about 60 publications, roughly divided into three types 
of publication: a) publications dealing with the development and validation of detection methods, 
b) individual case reports in which psychotropic drugs were detected and c) controlled dose 
studies. In order to prove the applicability of the validated methods (a), a few hair samples were 
often examined within the scope of these publications, but unfortunately often without any 
information on dosage or frequency of intake in the time before sampling. In the case reports (b), 
the dosage information was very variable from publication to publication. Furthermore, the hair 
lengths used in these two types of publications were very inconsistent, which greatly reduced the 
comparability of the data collected. The statistical power was also very low due to the small 
number of cases in these types of publications. In contrast, numerous controlled dose studies (c) 
could be found, where the conditions of investigation were much more comparable. They were 
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characterized by higher case numbers, precise dosage information and the analysis of uniform 
hair lengths. In these studies, collectives of patients with psychiatric disorders were often 
examined in whom a stable and long-term intake of psychotropic drugs could be assumed. The 
substances were selected based on the annual medication prescription report of the health 
insurance companies in Germany [13]. These include some substances that have been marketed 
for decades but have now been replaced by newer, more effective substances and are therefore 
prescribed less frequently. In addition, there were also substances that are currently very 
frequently prescribed. It became very clear that there were big differences in the research results 
for the different substances. For some substances that are very common today, there was 
sometimes little comprehensive data available, while some older substances that are less relevant 
today have been intensively researched in hair over the last 20 years. 
Amitriptyline, a tricyclic antidepressant (TCA), and mirtazapine, a tetracyclic antidepressant 
(TECA), will serve as comparative examples to illustrate this imbalance. Discovered in the 1950s 
and 1960s [75], TCA quickly became very common in the treatment of depression. However, due 
to their strong binding to the histamine H1 receptor [10, 11], TCA have a very strong side effect 
profile, characterized by strong sedative components and cardiotoxic components. The relatively 
high toxicity associated with this side effect profile [12] led to the continuous development of 
psychotropic drugs with fewer side effects. The TECA mirtazapine was approved in the USA in 
1996 and has significantly fewer side effects with the same antidepressant effect [76]. This 
development is also evident from the prescription rates in Germany [13]. There, the prescription 
rate of mirtazapine, at 183 million defined daily doses (DDD), is considerably higher than that of 
amitriptyline, at 81.4 million DDD [13]. On the other hand, mirtazapine also interacts with the 
histamine H1 receptor, albeit less strongly than TCA. This binding can also cause sedative side 
effects, but less strongly and less toxic than TCA [12, 77]. Now one could assume that mirtazapine 
could potentially occur frequently in forensic toxicological investigations for DFC or overdose 
deaths due to this wide prescription rate and mild sedative effect. However, the present review 
showed that there is a very limited data for the detection of mirtazapine in hair compared to the 
detection of amitriptyline in hair. While five publications with case numbers of more than five cases 
could be identified for amitriptyline, none of the publications for mirtazapine has a higher case 
number than three cases. It was also found that the hair lengths used varied widely between the 
investigations and only rarely a dosage was indicated. For amitriptyline, four studies with a high 
case number and dosage were identified, while for mirtazapine there was only one study with the 
stated dosage and a number of two cases. In summary, this results in a solid data basis for 
amitriptyline and a very weak basis for mirtazapine.  
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Against the background of numerous analytical aspects, the work also critically examines the 
comparability of quantitative data in hair. A successful method validation can already ensure a 
high degree of quality and comparability. It should be noted, however, that the production of 
calibration and quality control samples can hardly simulate real incorporation into hair. Likewise, 
the extraction method chosen can have a strong influence. Each laboratory has developed its own 
extraction procedure, so that even here a low level of comparability between the results is given. 
Today, comparability of results is ensured by so-called interlaboratory tests (or proficiency testing), 
in which a large number of laboratories examine hair samples with known concentrations. Spiked 
blank hair matrix is usually used for these tests although samples with an authentic incorporation 
from drug intake would be favorable. To date, unfortunately, no interlaboratory tests for 
psychotropic drugs in hair are available but would be urgently needed to demonstrate the 
suitability of the methods. Successful validation must therefore be considered sufficient as proof 
of confidence in the accuracy of the data collected. When using such data for own interpretations, 
these aspects should be taken into account. 
Through this work it could be shown that there is a lack of comprehensive quantitative data in hair 
for numerous psychotropic drugs. Furthermore, it was shown that the publications hardly showed 
comparable extraction protocols or examined hair lengths, despite the recommendations of 
numerous professional societies.  
In addition, the paper provides an important overview of the available scientific literature, which 
can provide other scientists with a quick and comprehensive overview and thus possibly assist 
them in their case work. 
 
3.1.2 Publication 
Methling M, Krumbiegel F, Hartwig S  
Hair analysis of antidepressants and antipsychotics - Overview of quantitative data. Drug 
Test Anal. 2020; 1– 18. https://doi.org/10.1002/dta.2784 
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3.2 Manuscript Ⅱ 
Toxicological findings in suicides – frequency of antidepressant and antipsychotic 
substances 
Reprinted with permission from Forensic Science, Medicine and Pathology, Copyright (2018), 
Springer Nature 
3.2.1 Summary 
Several evidence matrices including blood and hair samples are routinely taken during autopsies 
for further toxicological investigations in postmortem cases. Such samples are released for 
research by the public prosecutor's office and can be used for retrospective studies. In contrast, 
prospective studies with a prescribed drug intake on individuals are of high ethical concern. 
Retrospective studies are therefore a valuable way to achieve greater understanding in forensic 
research. As mentioned in the aims and objectives chapter, hair analysis is a time and cost 
intensive technique and therefore the selection of samples should be undertaken wisely. 
Therefore, identification of postmortem cases with a possible long-term intake of antidepressants 
or antipsychotics prior to death was chosen to approach this issue and to achieve an effective 
case selection. During the retrospective evaluation of earlier postmortem cases investigated, it 
became apparent that psychoactive substances were very frequently detected in suicides. With 
the emerge of the selective serotonin reuptake inhibitors (SSRI) in the early 1990s and 2000s 
controversy about suicidality-inducing effects was raised by some case reports [78-80]. This 
hypothesis was then addressed by many different perspectives but remained a controversy due 
to divergent results from different approaches. It cannot be denied that these substances have a 
relatively high toxicity and broad side effect pattern although they are a major factor in the 
treatment of mental disorders [81, 82]. Out of this observation a cross-sectional study was 
conducted to not only identify possible positive cases for a later hair analysis but to give insight 
on the prevalence of antidepressants and antipsychotics in suicides, at least in this region.  
The federal state of Berlin has a unique structure in the processing of death investigations where 
the autopsies are performed at two institutes of equal standing: the Institute of Legal Medicine and 
Forensic Sciences at the Charité University Medicine Berlin and the Berlin State Institute of Legal 
and Social Medicine. This study only observed cases from the Institute of Legal Medicine and 
Forensic Sciences at the Charité University Medicine Berlin during the period of 2012 - 2015 with 
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about 4000 performed autopsies. Generally, an autopsy is not ordered by the public prosecutor's 
office in every case of suicide, therefore not all suicides during that time were covered. In 2600 of 
the cases from the Charité University Medicine Berlin a comprehensive toxicological investigation 
was performed. Venous blood, heart blood, urine and other organ tissues as well as hair samples 
are routinely taken as evidence during an autopsy. For a systematic toxicological analysis 
preferably blood or urine samples are investigated (if available), although organ tissue can also 
be analyzed to prove an acute (brain tissue) or subacute exposure (liver, kidney) to a substance. 
The toxicological investigations were performed with published and validated high-performance 
liquid chromatography with diode-array detection (HPLC-DAD) [83], LC-QTOF-MS [14], 
LC-QQQ-MS and gas chromatography flame ionization detection (GC-FID) [84] methods. All 
cases with positive findings for TCA (amitriptyline, clomipramine, doxepin, opipramol, 
trimipramine), SSRI (citalopram, fluoxetine, paroxetine, sertraline), TECA (mirtazapine, 
maprotiline), atypical neuroleptics (ATYP: amisulpride, clozapine, olanzapine, quetiapine, 
risperidone), typical neuroleptics (TYP: chlorprothixene, haloperidol, melperone, promethazine, 
zuclopenthixol) and other substances with antipsychotic or antidepressant effects 
(tranylcypromine and venlafaxine) were included in this study. Other information like gender, age, 
cause of death, mental disorders, location of death and blood alcohol level were also included. 
Overall n = 447 cases with positive results for antidepressants and antipsychotics were identified 
and divided into the non-suicide cases (n = 212; male n = 117, 55.2 %; female n = 95, 52.5 %) 
and suicide cases (n = 235; male n = 149, 63.4 %; female n = 86, 36.6 %). The classification was 
based on the final investigation results of the public prosecutor's office and the final autopsy report, 
including the cause of death. An evaluation of the gender distribution showed a ratio of 2:1 for 
male to female cases which is in line with nationwide trends [85] and other cases from the institute. 
A similar trend was evident for the age distribution [85]. The included cases therefore appeared 
to be a suitable cross section of the national population. Higher frequencies were found for almost 
all drug classes in the suicide group and may be explained by the higher number of cases with 
more than one drug detected in the suicide group (37.5 % suicide group vs. 22.7 % non-suicide 
group). Several reasons for this observation were discussed: combination of treatment regimens 
or histories of failed and non-effective treatment regimens that led to a higher access to such 
drugs for some patients. A gender evaluation of the suicide group showed similar results for males 
and females except for ATYP that were more frequently detected in males. Our findings were 
compared to the results of a group from Munich [86] that investigated an earlier time period. The 
observed changes in the frequencies were discussed as possible reflection of the changing 
prescription rates. A mental disorder was known for 22.9 % of the suicide cases and the most 
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common location of death was at home. The most prevalent causes of death were drug overdose, 
followed by polytrauma and hanging. The portion of drug poisonings included more female than 
male cases (41.2 % female vs. 31.2 % male). Split by drug class it was evident that TCA were the 
most frequently detected drugs by far (followed by SSRI, ATYP, TYP, TECA and others). That 
observation was discussed and related to the individual toxicity of the substances which is, 
expressed as the fatal toxicity index in overdose, far higher for TCAs than for the other classes 
[12]. The detailed evaluation of the substances showed the five most frequently detected 
substances found in the suicide group: doxepin (20 %), citalopram (15.3 %) mirtazapine (14.9 %), 
quetiapine (13.6 %) and amitriptyline (12.3 %). It was discussed that this ranking might be related 
to a complementary effect of the individual toxicity [12] and the prescription frequency [13] (for 
example citalopram with high prescription rate, but a low toxicity). In contrast, this ranking was 
different in the non-suicide cases: citalopram (15.6 %), doxepin (13.7 %), mirtazapine (12.3 %), 
amitriptyline (8.5 %) and melperone (8.5 %). Alcohol and suicidal behavior are somehow related 
in a complex way since drinking alcohol in a phase of suicidal ideation can remove inhibitions and 
lower the resistance to committing suicide [87]. In this study, alcohol was detected in about one 
third of the suicide cases compared to about one fifth of the non-suicide cases. Comparable 
proportions were also found by other studies [88-90].  
The comprehensive investigation of a wide number of substances is a major strength of this study 
as previous studies did not include so many drugs. Also, often only classes of drugs were 
presented and not detailed data on single substances. The preselection bias that is based on a 
regional bias (only half of the autopsies in Berlin were included due to the structure of two equal 
forensic institutes) and the fact that not all suicides are investigated was intensively discussed. 
Finally, the advantages of this complementary approach to assess the risk of suicide during 
medical treatment and its possible role in suicide prevention were pointed out.  
3.2.2 Publication 
Methling M, Krumbiegel F, Hartwig S, Parr MK Tsokos, M  
Toxicological findings in suicides – frequency of antidepressant and antipsychotic 
substances. Forensic Sci Med Pathol 15, 23–30 (2019) https://doi.org/10.1007/s12024-018-
0041-4 
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3.3 Manuscript Ⅲ 
Concentrations of antidepressants, antipsychotics and benzodiazepines in hair samples 
from postmortem cases  
Reprinted with permission from SN Comprehensive Clinical Medicine (Open Access, Creative 
Commons CC BY), Copyright (2020) Springer Nature 
3.3.1 Summary 
The aim of this work was to comprehensively expand the data set for psychotropic drugs in hair 
based on the analysis of hair samples from selected postmortem cases. Sensitive, reliable and 
reproducible detection methods are essential for determining quantitative data in hair. The first 
step of this work was therefore the development and validation of an LC-QQQ-MS method for the 
detection of psychotropic drugs in hair and the subsequent validation to prove the suitability of the 
method. In the second step, 442 postmortem hair samples were examined with this method to 
present quantitative data for psychotropic drugs in hair based on sufficiently high case numbers. 
The selection of the substances to be detected was based on the annual prescription report of the 
health insurance companies for psychotropic drugs [13] and included antidepressants, 
antipsychotics and benzodiazepines. In total, 52 analytes were included in the method 
development, including 8 metabolites to consider possible metabolite-parent drug relationships. 
After successful optimization of the mass transitions required for the LC-QQQ-MS method, a 
gradient elution was established, which allowed the clear separation of the analytes. 
Subsequently, the method was comprehensively validated according to the guidelines of the 
GTFCh [15]. The parameters described in 2.3.2 were all fulfilled, so that the method could be 
successfully validated for all 52 analytes. The linear calibration range for most substances was 
between 0.005 ng/mg and 2.5 ng/mg, with some analytes showing slightly smaller linear ranges 
of 0.05 ng/mg - 2.5 ng/mg. The range of the limits of quantification was very low with 1.2 - 37 
pg/mg in hair. 
Based on the previously conducted observational study (chapter 3.2. [91]), a large number of 
cases with confirmed intake of psychotropic drugs, at least at the time of death, could be identified. 
In addition, cases were included in the study where the investigation file showed that the patient 
had taken psychotropic drugs in the past. In total, hair samples from n = 442 cases were then 
included in the study and examined.   
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For sample preparation, the hair samples were segmented into two segments (0-2 cm and 2-4 cm) 
close to the head, if the quality of the sample allowed this. In this way n = 258 samples could be 
examined segment by segment, while the remaining hair samples were too short or too knotted 
and were examined in their entire length. Little or no reliable background information on the 
dosage taken was known for the individual cases. Even if there is evidence from the investigation 
file in this regard, there is still a residual uncertainty whether these drugs were taken properly. In 
postmortem cases it is also very difficult to determine whether aggressive treatment of the hair 
was present. For this reason, hair samples with aggressive treatment of the hair may also be 
among the cases examined.  
From the n = 442 investigated cases, n = 22 hair samples were negative and n = 420 hair samples 
revealed quantitative data for 41 substances and 8 metabolites. In order to address the differences 
in the investigated hair lengths and the uncertainty in the intake, a presentation of the data in 
percentiles was chosen. This approach was also found suitable by Musshoff et al [92], Tsanaclis 
et al. [17] and Wang et al. [93] and allows to show strong variations in hair length or the context 
of the samples of the study. It was also suggested [92, 94] that each laboratory should keep its 
own statistics based on this approach. The results were then divided into two groups, the group 
of segmented cases and the group of segmented and non-segmented cases. In the group of 
segmented cases, numerous data from comparable examination lengths and time periods could 
thus be presented. The group containing the segmented and non-segmented samples lost this 
comparability but was able to present much more additional data for many substances (e.g. 
amisulpride: n = 26 in group 1 vs. n = 43 in group 2). 
From the previous study it was known in which cases antidepressants or neuroleptics were 
detected at the time of death. This allowed the comparison of the acute and chronic intake of many 
substances. It was found that there were cases where something was found only in the hair but 
not at the time of death, as well as cases where these substances were detected in both matrices. 
However, the results differed widely between the substances, so that no real trends could be 
deduced. As possible reasons for the sole detection in a particular matrix, adherence in the context 
of drug therapy or the frequent change of medication were discussed. 
External contamination of the hair can occur very quickly in postmortem hair and is a major 
problem for the interpretation of such findings. Kintz et al. [95] discussed the postmortal 
incorporation of drugs into the hair from body fluids (e.g. blood, sweat, or putrefaction fluid), from 
environmental pollution, or excessive sweating during a long agonal phase in the process of dying. 
It was suggested that the results of segmental analysis could indicate contamination if the 
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concentrations are homogenous or consecutive. The investigator should be aware of these 
mechanisms in order to avoid false interpretation of long-term exposure. In addition, metabolite 
parent drug ratios are also used as possible indicators for the distinction between external 
contamination and systemic incorporation [96]. As part of the work, these mechanisms and 
possibilities of interpretation were shown for four selected cases. The results of the blood tests, 
the circumstances of the cases, the results of the segmental hair analysis and metabolite-parent 
drug ratios were discussed in detail to illustrate the complexity of the topic. Without the metabolite-
parent drug ratios collected in this study, such a comprehensive consideration would be 
impossible. 
Despite the limitations regarding the uneven hair lengths, the unknown hair cosmetics (which can 
decrease hair concentrations) and the missing information on the ingested dose, this work has 
made a valuable contribution to the expansion of data on psychotropic drugs in hair. For some 
substances very high case numbers (partly more than 100 cases) compared to other studies were 
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3.4 Manuscript Ⅳ 
The use of nails as an alternative matrix for the long-term detection of previous drug intake: 
validation of sensitive UHPLC-MS/MS methods for the quantification of 76 substances and 
comparison of analytical results for drugs in nail and hair samples. 
Reprinted with permission from Forensic Science, Medicine and Pathology, Copyright (2016), 
Springer Nature 
3.4.1 Summary 
In the work of Krumbiegel et al. [18] it was shown that nails can be used as an alternative 
retrospective examination matrix for undirected search analyses. The present work continued the 
comparative investigation of hair and nails using quantitative data. For this purpose, two 
LC-QQQ-MS methods for the determination of 76 analytes (narcotics, psychotropic drugs) in hair 
and nail were first developed and successfully validated according to the guidelines of the 
GTFCh [15]. The LLOQ values ranged between 1.23 and 98.6 pg/mg for hair samples and 
between 0.95 and 46.7 pg/mg for nail samples, providing very sensitive detection. 
For the comparative study of hair and nails, 7 postmortem cases with a known history of drug 
abuse were selected. In each case, samples were taken before autopsy, with whole nails being 
taken in five highly putrefied cases and clippings in two cases. The special focus of this work was 
the chosen segmentation of both hair and nail samples. This allowed similar examination periods 
to be considered for both matrices and helped to estimate possible ways of drug incorporation in 
the nail. By segmenting whole nails, it was possible to investigate areas in which different 
incorporation mechanisms are important. A whole nail sample was divided into four different 
segments: A (nail clipping), B (only the bottom of the nail plate), C (segments of nail plate excluding 
the bottom), D (segments of the complete nail plate). It was shown that the substance 
concentrations in the individual segments in hair and nails are not comparable. For all cases, nail 
and hair concentrations of drugs of abuse where found, while also quantitative data for four 
antidepressants (doxepin, trimipramine, mirtazapine, opipramol) and methylphenidate was found. 
Based on the investigation results of the individual cases, different ways of incorporation in the 
nail were then discussed.  Especially in the clippings, higher concentrations were often found than 
in other nail segments, which was hypothesized to be based on an acute intake prior to death. 
The incorporation of drugs from sweat or external contamination into the free edge of the nail were 
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discussed as possible reasons for this observation. Due to the highly variable concentrations 
between the individual nail segments, it was assumed that incorporation via the geminal matrix 
must be one of the main routes. A drug incorporation from the nail bed into nail following drug 
intake (via the blood) appeared to be negligible. One case showed positive findings for heroin 
metabolites in only one nail segment and in the clipping. It was assumed that this was due to 
heroin uptake a long time ago. A drug incorporation via blood during the formation of the nail at 
the nail root was discussed in this case. The significantly lower concentrations in the clipping were 
attributed to a possible external contamination for a longer time before death. Furthermore, 
concentration ratios of metabolites and parent substances for some drugs were considered and 
compared for hair and nails. The metabolite ratios for (3,4-methylenedioxyamphetamine) MDA/ 
(3,4-methylenedioxymethamphetamine) MDMA, 2-(ethylidene-1,5-dimethyl-3,3-
diphenylpyrrolidine) EDDP/methadone, and the metabolites of tilidine bisnortilidine/nortilidine 
were similar in the nail and hair samples in five of the different cases. It was assumed that this 
points to a similar incorporation, probably via the blood during the formation of the matrix. In one 
case, however, the ratio for EDDP/methadone was significantly higher in nails compared to hair. 
This observation was discussed against the background of increased sweating under methadone 
substitution. In this constellation, increased incorporation due to sweating could lead to altered 
incorporation rates. Differences in the concentration ratios of hydrolytically sensitive analytes such 
as cocaine or 6-acetylmorphine were discussed on the basis of sample preparation. This was 
shown in more detail in case 5, were the results of hair cut into small pieces were compared with 
grounded hair. The concentration in the cut hair was significantly higher than in the grounded 
hairs. The heat generated during the grinding process was discussed as a possible reason for 
hydrolysis and the associated loss of substance. 
In summary, quantitative data for substances in nails were presented and compared with hair in 
temporally similar segments. Despite the non-comparable substance concentrations in both 
matrices, it was assumed that the incorporation pathways in hair and nails are comparable, as 
similar metabolite ratios were determined for some substances. In addition, quantitative data on 
some antidepressants and methylphenidate was presented. 
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3.5 Manuscript Ⅴ 
Ethylglucuronide as a biomarker for alcohol consumption – a comparison between hair 
and nails (publication in german language) 
Reprinted with permission from Blutalkohol, Copyright (2017), Steintor-Verlag 
3.5.1 Summary 
It has already been pointed out in the previous chapter 2.2 that retrospective examination of hair 
is not always possible in cases of sparse hair growth or intentionally shaven hair. In addition, in 
postmortem toxicology there may cases of prolonged decay or severe burning of the body. In 
order to have a possibility to assess the long-term drug intake in such cases, the research of 
alternative matrices is all the more important. The present work dealt with the incorporation of the 
direct alcohol consumption marker EtG into nails in the context of postmortem toxicology. In 
addition to nail edges, hair samples were also examined. First, an LC-QQQ-MS method for the 
detection of EtG in nails and hair was developed and successfully validated according to the 
guidelines of the GTFCh [15]. For the validation, hair and nail edges of children were used as 
blank matrix.  A linear calibration range of 6.5 - 208 pg/mg for hair and 6.5 - 417 pg/mg for nails 
was achieved. The limit of quantitation was 1.49 pg/mg for hair and 3.49 pg/mg for nails. 
Following successful validation, a collective of living subjects (n = 18) and a collective of 
postmortem cases (n = 19) were examined. The living subjects answered a questionnaire on their 
drinking behavior over the last 3 months before inclusion in the study, whereupon only subjects 
with normal drinking behavior were included. Furthermore, six of the test persons stated that they 
lived abstinently. Only cases were included in the group of deaths in which public prosecutor's 
investigation files provided reliable evidence of chronic excessive alcohol consumption in the last 
months before death.  
From both groups a 0-3 cm long proximal hair section and the protruding free nail edge ("clipping") 
were examined. In the postmortem cases, samples were taken before the autopsy in order to 
avoid possible contamination by the body fluids leaking during the autopsy.  
The results of the study of the group of living normal drinkers showed on average a higher 
concentration of EtG in nail clippings than in hair, although the extent of the increases is still 
subject to fluctuations. However, it could be shown from the samples of the abstinent subjects that 
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the negative findings of the hair analysis could also be confirmed by nail analysis. Previous studies 
by Berger et. al [97] and Morini et. al [98] also showed higher average EtG concentrations in the 
nail. In the group of the postmortem cases a much more diffuse picture with highly fluctuating EtG 
concentrations was evident. The concentrations in the nail were partly significantly higher than in 
the hair, but not consistently in all cases examined. 
Various reasons for these results were compared and discussed. Many aspects can play a role 
here, such as different examination time periods for nails and hair, external contamination by 
putrefactive or bodily fluids or influences by unknown hair cosmetics in postmortem cases. Since 
external contamination is a known problem in post-mortem cases, it seems likely that it can also 
affect the concentration in the nail [95]. The paper also examined the hitherto little understood 
incorporation mechanisms for substances in nails and discussed the measured concentrations as 
a combination of internal incorporation and external incorporation over a longer period of about 
3-5 months [57]. Studies to clarify the incorporation mechanisms of EtG in nails were not known 
at this time. Because of its high water solubility, the deposition of EtG in hair was assumed mainly 
external through sweat [1]. It was discussed to what extent this can be transferred to nails in the 
sense of accumulation of sweat under the nail edge. As limitations of the study, non-comparable 
examination periods of nails and hair were discussed as well as the lack of clarity about the actual 
consumption of alcohol in fatalities. 
3.5.2 Publication 
Methling M, Neumann M, Krumbiegel F 
Ethylglucuronid als Alkoholmarker – Haare und Fingernägel im Vergleich. Blutalkohol 
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4 Delimitation of own contribution 
In the following the author's own contributions to the individual publications, which are the basis 
for this cumulative work, should be presented in detail. 
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5.1 Contribution of the results to the scientific community 
Forensic toxicological investigations in many contexts can require a retrospective investigation of 
a substance use over a longer period of time. Such contexts can include: Parental custody 
disputes, abstinence issues, assessment of past substance use, DFC cases, assessment of 
habituation in postmortem examinations, assessment of past alcohol consumption and 
compliance control. Within these contexts, questions may arise that require a distinction between 
abstinence, single intake or frequent intake or substance habituation. Within certain limits, hair 
and nail analysis can help to assess these questions. Psychotropic drugs (antidepressants, 
antipsychotics, benzodiazepines, alcohol) are a class of substances that may appear frequently 
in the daily routine of a forensic toxicologist, due to their widespread prescription frequency [13], 
easy accessibility (alcohol) and relevant toxicity [12]. However, most routine hair tests in forensic 
toxicology laboratories usually only include drugs of abuse or the examination of drinking behavior 
using direct alcoholism markers. The investigation of nails as an alternative matrix, in cases where 
no hair is available, is established to an even lesser degree in most laboratories. Situations in 
which psychotropic drugs are used, for example, as sedatives with criminal intent or in the context 
of postmortem examinations, where it is decisive how the previous intake was, are thus a great 
challenge in everyday forensic work. To meet this challenge, it is necessary to consider various 
research aspects: a) the availability of comparable data, b) the ethically correct and as 
uncomplicated as possible collection of data with reliable detection methods, c) the assessment 
of the validity of such data, d) the knowledge of substance incorporation and associated pitfalls 
and interpretation approaches. The general aim of this work was to take a comprehensive look at 
these aspects to ensure a very well-founded interpretation of the retrospective detection of 
psychotropic drugs in hair and nails. This was achieved by means of various types of studies and 
newly developed and validated analytical methods.  
In a general overview of the available research, it turned out that psychotropic drugs were 
examined in some studies, but that both the comparability among the studies was very poor and 
some substances were examined very rarely. The lack of comparability was mainly due to the 
inconsistent use of hair lengths as well as the often-missing information on the actual intake or 
dosage. On the other hand, methods with very low limits of detection were presented and 
validated, allowing the detection of smallest amounts in low pg/mg concentration range. This is 
necessary if a discrimination is to be made between a single exposure or a long-term exposure 
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using hair analysis. One reason for the poor examination of many substances may be the ongoing 
development and marketing of new psychotropic drugs. However, this results in an imbalance in 
the data when there are some well-researched substances that may not be prescribed frequently, 
in contrast to drugs that are frequently used today and have hardly been researched in hair 
analysis. The available data for amitriptyline, a TCA, and mirtazapine, a TECA, in hair were 
compared and discussed to illustrate the situation. The mentioned lack of sufficient data on 
mirtazapine in hair may become fatal if the detection and interpretation of mirtazapine in hair 
becomes necessary. With increasing prescription rates and sedative effects, this situation may 
become more common in the future. This imbalance has been shown for several other substances 
and in the long run leads to a much more difficult interpretation of the detection of psychotropic 
drugs in hair. A different focus in the use and prescription of psychotropic drugs across countries 
can further exacerbate this situation for individual substances. In situations where no hair is 
available, interpretation of such forensic cases is very difficult without proper data. For the analysis 
of nails, the situation is even worse, as almost all available studies focus on drugs of abuse.  
This hence revealed imbalance of quantitative data was to be counteracted within the framework 
of this thesis. Various considerations were made to find an appropriate study design. Controlled 
retrospective studies with comparable hair lengths and known dosages may be the most profound 
way to obtain data of high quality. Such data collection in the context of research work can only 
be done indirectly with patients that already take this medication. Ethical considerations forbid that 
healthy living test persons are affected in their health by the intake of medication only for the 
purpose of research on hair concentrations. These retrospective studies can only be realized in 
the context of clinical co-operations with psychiatric institutions. A co-operation requires 
adherence to strict ethical standards and extensive planning and time. After successful approval 
of the performance of such a retrospective examination, the recruitment of suitable patients takes 
a lot of time. Tight inclusion criteria such as sufficient hair length, no use of aggressive hair 
cosmetics and a proper intake of the prescribed medication for at least three months mean that 
the selection of potential patients is already very limited. The relationship of trust between 
recruiting physician and patient is also crucial for successful recruitment, since patients are likely 
to have a mental disorder when taking psychotropic drugs. In order to avoid the major hurdles in 
conducting such studies, an alternative approach was chosen. Data collected in the context of 
forensic toxicological investigations of postmortem cases may be used for retrospective research 
purposes with the permission of the Berlin public prosecutor's office. A disadvantage of this study 
approach is the often-insufficient information about the existing medication of the deceased and 
the uncertainty about the actual intake in the last months before death. This requires special 
 Discussion           107   
 
 
attention in the subsequent evaluation and interpretation of such data compared to controlled dose 
studies. T, a retrospective investigation of hair samples from postmortem cases with known 
psychotropic drug use from the Institute of Legal Medicine and Forensic Sciences at the Charité 
University Medicine Berlin was conducted. A pre-selection of cases was necessary because the 
sample preparation of hair and the sample extraction is very time consuming and costly. Due to 
the high effort involved, hair analyses are often not routinely performed in postmortem 
investigation procedures. Even in the investigation files of the public prosecutor's office there is 
only rarely any indication of psychotropic drug use. It can at least be assumed that a person who 
was under the influence of psychotropic drugs at the time of death may have been taking these 
substances for a longer time, and consequently the hair sample may give a positive result. These 
cases can then be selected for a comprehensive examination of the hair samples. The 
retrospective evaluation of postmortem cases for this pre-selection process showed a high number 
of suicides with positive findings for antidepressants and antipsychotics. This observation was 
pointing to the urge for an investigation of the prevalence of antidepressants and antipsychotics 
in suicides and non-suicides. In this cross-sectional study, it was shown that the toxicity and 
prescription frequency of certain substances was reflected in the frequency of their detection in 
postmortem cases. In addition, numerous cases with a certain intake of psychotropic drugs close 
to the time of death were identified for further hair analysis. Psychotropic drugs are a special type 
of medication because on the one hand they are very important in the treatment of mental disorder, 
but on the other hand they have strong side effects. In addition, in the 1990s there were the first 
reports of an increase in the risk of suicide when taking such substances [78-80]. Since then, 
research into this risk has been a continuous focus of various study approaches. The presentation 
of prevalence data at the actual endpoint, death, represents an important further approach. The 
differentiation of the results into the group of suicides and non-suicides also showed higher 
detection rates for suicides. Otherwise, an examination of gender differences in the group of 
suicides showed no major differences in the detection frequencies. In summary, TCA were found 
most frequently, followed by ATYP, SSRI, TYP, TECA and venlafaxine in both the suicide and 
non-suicide groups. Several cautious conclusions can be drawn from these results. First, that 
people who committed suicide were more likely to be under drug treatment. On one hand, this is 
a positive development, as it shows that many of these people at risk of suicide were under 
treatment. The distribution of the respective groups of therapeutic agents can represent both their 
prescription frequency and their actual toxicity. This was made clear by the example of TCA, which 
are the most frequently detected, even though they are less frequently prescribed than SSRI in 
terms of numbers [13] but are significantly more toxic due to their side effect profile [81, 82]. It can 
therefore be assumed that these two effects can cause these results. It was also shown that the 
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deceased in the suicide group were more often under the influence of several substances at once. 
Since drug therapies are often changed in the context of mental disorder until the desired effect 
occurs, it is quite possible that some of the deceased were treated with many different drugs in 
the near time of death. It was also found that alcohol was detected in about one third of all suicides, 
which was consistent with previous studies [88-90]. A limitation of this investigation, however, 
remains the regional bias and the bias that arises, since not all deaths and suicides in Berlin are 
included in this investigation. The results of the sample studied can therefore only be applied with 
limitations to a larger population. In studies with a similar approach, individual classes of 
substances were usually examined, but rather rarely the evidence of individual substances was 
presented [88, 99, 100]. The joint consideration of the most common antidepressants and 
neuroleptics has not yet been published in this form. The comprehensive investigation of the 
postmortem detection of antidepressants and neuroleptics in suicides and non-suicides in the 
context of this publication thus contributes as a complementary approach to research into the risk 
of suicide while taking psychotropic drugs. With this study, numerous cases with secured 
psychotropic drug use were identified for a further hair analysis.  
These analyses were conducted with a newly developed method for the quantification 
psychotropic drugs in hair. The LC-QQQ-MS method for the detection of 52 substances 
(antidepressants, antipsychotics, benzodiazepines) in hair was successfully validated according 
to the guidelines of the GTFCh [15]. The successful validation proves that the method provides 
precise and comparable results. However, some analytical considerations concerning the 
preparation of calibration samples and quality control samples for hair analysis must be 
addressed. Cuypers et al. [101] and Xiang et al. [94] point out that the preparation of such samples 
can be done in three different ways, each with its own problems. Both the spiking of washed 
negative hairs with analyte solution and the soaking of negative hairs (fortyfing) in analyte solution 
do not exactly produce extracts of authentic hairs in which the substances have been incorporated. 
Even the approach of decontaminating and homogenizing authentic hair samples bears the risk 
of losses during decontamination and thus altered hair concentrations. External verification of the 
method by means of proficiency testing would provide further assurance against. Unfortunately, 
the available proficiency tests in hair do not yet include any of the psychotropic drugs investigated. 
These limitations must always be considered for hair analyses, despite the great performance of 
the methods used.  
The consecutive analysis of hair samples (n = 442) from the previously identified cases with known 
psychotropic drug intake before death and samples with an assumed past drug use provided 
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quantitative data for 41 substances and 8 metabolites. High case numbers for some substances 
and above all new data for substances that have been rather poorly investigated so far were 
presented. This study thus makes an enormous contribution to counteracting the insufficient data 
basis for many substances. Due to the postmortem context, very little information is often available 
on how long a deceased person took which drug, in which dosage (and which application form) 
and how regularly he or she took it. Such information cannot be verified with certainty in 
postmortem cases either, since there is always a residual uncertainty concerning the actual intake. 
As already criticized in the previous sections, the knowledge about dosage and compliance is 
extremely important in order to use quantitative data for comparison for later interpretation of own 
hair analyses. However, as this remaining uncertainty on dosage cannot be excluded for this type 
of investigation, and correlation with dosage is therefore impossible, a different approach for the 
statistical evaluation of data was chosen. All detected hair concentrations were displayed in 
percentiles as strong variations concerning the context of the sample or variations in the used hair 
length can thereby be addressed. Other authors [16, 17, 92, 93] outlined the usefulness of this 
approach as well and propose that each laboratory should build its own statistics around it. The 
concentration ranges obtained in this way can be used for a rough and comparative estimation of 
a past intake frequency. The individual ranges between the percentiles can be assigned and 
interpreted the following way [16]: the lower range between the minimum to the 25th percentile, 
the middle above the 25th to the 75th percentile and the upper range above the 75th percentile. For 
drugs of abuse and pharmaceuticals the individual ranges were interpreted differently: the lower 
range is to be predictive of moderate use of drugs of abuse and the upper range to be linked to a 
heavy consumption [16]. Middle range concentrations were assigned for drug misuse while 
concentrations above the 95th percentile could suggest excessive consumption [16]. For 
pharmaceuticals and legal drugs, the lower range is associated with a misuse in the recent past 
or a current proper use [16]. The middle range may suggest an actual administration of high doses 
or a misuse while the upper range can be associated to administration of unusual high doses, 
dependency or tolerance [16]. To what extent this applies to psychotropic drugs cannot be clarified 
at this point, but nevertheless this proposal provides an important basis for interpretation. For the 
investigated postmortem cases within this study, concentrations above the 95th percentile may 
also indicate cases with possible external contamination. A comparison of the present work with 
the work of Musshoff et. al [16] shows a satisfactory conformity of the concentration ranges for 
numerous substances with partly similar case numbers. Although the hair samples originated from 
a different context (criminal offense or custody cases) and a different sample preparation was 
used in this publication [16], similar concentration ranges are achieved in both laboratories. The 
comparison also shows that the investigation of larger numbers of cases and the associated 
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statistical significance can lead to better comparability of results. This is particularly exciting, as 
significantly higher concentrations may occur in postmortem cases, due to external contamination. 
The comparison may thus suggest that the concentration ranges presented in this work from 
postmortem cases may be artificially increased only to a small extend by cases with possible 
external contamination. Thus, a good comparability and transferability of the presented data to 
samples from living subjects seems acceptable. Nevertheless, hair concentrations from controlled 
dose studies should have the greatest benefit for an estimate of past frequency of use. Despite 
uniform validation guidelines, each laboratory uses its own decontamination and extraction 
procedures, so that the detected concentrations may differ between two laboratories. Due to the 
aforementioned lack of proficiency tests to ensure similarity, it is even more important that 
laboratories use statistics as described above. Despite different methods in other laboratories, the 
concentrations determined in this study can help other scientists to interpret their own findings 
cautiously, also in view of the fact that they themselves may perform such analyses too rarely and 
thus obtain sound statistics. However, since very few laboratories carry out hair analyses at all 
and even fewer laboratories study psychotropic drugs in hair, it is very important to share the 
results of this work. Since many cases would have been excluded from the study due to differing 
hair lengths, the results were divided into the group of segmented samples and the combined 
group of segmented and non-segmented samples. The grouped presentation of the results for the 
hair analyses allows comparable hair lengths for the group of segmented samples. By including 
the non-segmented samples, many more cases could be presented, but their results are to be 
considered within the limits of the non-comparable hair lengths and investigation periods. A major 
limitation of this study is the often-unknown hair cosmetic treatment in postmortem cases. 
Aggressive hair cosmetics such as bleaches and dyes can lead to a significant reduction of the 
analyte concentration in the hair. In living persons, it is therefore essential to ask for and record 
hair cosmetic treatments when taking samples. In the postmortem cases, this inquiry is rarely 
possible, although the extracted sample buffer can be colored if certain cosmetic treatment was 
applied. This limitation should be considered when interpreting the data. Despite the limitation of 
the study mentioned above, the approach of indirectly obtaining quantitative data via retrospective 
postmortem studies is still very useful in order to further explore the research area on an ethically 
justifiable basis.  
The examination of hair samples from previously selected cases with an intake of psychotropic 
drugs at the time of death allows a comparison of the acute intake and the long-term intake of 
these substances. In the examined collective, a full agreement of the results in both examined 
matrices up to an exclusive detection in the hair was shown, depending on the substance. If the 
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results from blood (or urine and organs) positive for a substance, but negative in the hair sample 
this may indicate that a medication has been discontinued as part of a failed drug treatment. The 
clarification of this history of use would not be possible without a hair analysis and may be helpful 
for further investigation in certain cases. However, it is not possible to derive trends for individual 
substances with regard to their efficacy or hazardousness from these data. 
The already mentioned lack of sufficient studies on psychotropic drugs in hair also concerns their 
metabolites. Only a few studies at all have dealt with these degradation products and presented 
data on them [35, 93]. With the present work and the presentation of high case numbers for 8 
metabolites and the corresponding metabolite-parent drug ratios, an important contribution was 
achieved. In the course of the study it was also shown how a possible external contamination by 
body fluids can be clarified by using a segmental hair analysis [95] and the investigation of 
metabolite/drug ratios. This would never have been possible without the metabolite-parent drug 
ratios identified in the study and the segmental analysis. Especially in forensic investigations it is 
of enormous importance to avoid false positive results. They can occur due to technical reasons, 
for example sample mix-ups or problems during analysis, or they can be caused by passive 
exposure to drugs. The topic of external contamination and thus the possible falsification of 
interpretation in hair analysis results is currently being intensively discussed [96]. Various 
investigations have shown that the deposition of substances from the outside onto the hair, in the 
sense of external contamination, is possible by different scenarios. It has been shown that staying 
in rooms where cannabis products are smoked [103] or contact with cocaine dusts can lead to 
positive results in hair analysis [103]. Intensive washing protocols are often performed during 
sample preparation. The detection of a substance in the washing solution can be an indication of 
external contamination. The detected concentration in the hair should be a factor of 10 higher than 
the concentration in the wash solution to exclude contamination [112]. In addition, the study of 
different metabolites and their relation to the parent substance was proposed to distinguish true 
uptake from external contamination The search for suitable metabolites to detect systemic uptake 
into the hair is therefore still an intensively investigated field of research [104, 105] and the 
investigations in this thesis have contributed significant data for this purpose. 
With the help of the comparative work on nails and hair in two further investigations, important 
aspects about the incorporation pathways in nails and the application of nail analysis could be 
gained. The successful development and validation for the detection of EtG as well as drugs of 
abuse and psychotropic drugs in nails and hair provides a good basis for further quantitative 
investigations. Due to the low detection limits of both methods, it is possible to detect even very 
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low concentrations and thus possibly also one-time recordings of substances. In the case of DFC 
cases, this is highly desirable in order to provide decisive information for the solution of such 
cases. Both publications showed that the concentrations in the nail edges are not comparable with 
the hair sections that were comparable over time. In accordance with results from other authors 
higher EtG concentrations were found in the nail clippings compared to 3 cm of proximal hair 
[97, 98, 106]. It was shown that fingernails are suitable as an alternative matrix for the investigation 
of drinking behavior over a longer period of time. It was discussed whether EtG could be deposited 
in the nail mainly via sweat and the different time windows investigated. Nail clippings cover about 
3-5 months before sampling compared to 3-6 months for 3 cm hair [57]. It should be noted, 
however, that the concentration found in nail clippings is a mixture of internal and external 
deposition via sweat [57] and thus seems difficult to compare with the usual cut-offs for EtG in 
hair. Cappelle et al. [106] mentioned similar implications from the observation of higher EtG 
concentration in nails: a) analysis of nails can be interesting for expected low EtG concentrations 
and b) established hair analysis cut-offs by the SoHT [8] are not valid for nail analysis and future 
studies should focus on establishing cut-off values for EtG which are relevant for nails. However, 
a good agreement between the stated drinking amount and EtG concentration in nail and hair was 
found in the presented work and further work [106]. Recently, the SoHT proposed a lower cut-off 
of 5 pg/mg EtG in hair for the discrimination of abstinence and normal drinking behavior [107]. In 
anticipation of this lower limit, the detection method for EtG in hair has now been established on 
a new LC-MS/MS device with a better performance in the low limits of detection. Nevertheless, 
the examination of nail clippings is suitable for the investigation of total abstinence, as could be 
shown by our results. The detection of EtG in fingernails in postmortem cases has not yet been 
presented in any other study. The very diffuse results obtained here once again illustrate the 
strong influence of possible external contamination by body fluids. For the drugs of abuse and 
psychotropic drugs, there were also differences between the concentrations of hair and nails. 
Based on the results of both investigations, however, it is not possible to say whether the 
concentrations in the nail are generally higher than in the hair. The successful segmentation of 
whole nails allowed important insights into the incorporation pathways in the nail. Since the 
respective substance concentrations between the segments varied widely, metabolite ratios were 
used. Here it was shown that the concentration ratios (with some exceptions) in the nail and hair 
are approximately the same, as could also be shown by Madry et al. [108] for MDMA and its 
metabolite MDA. Therefore, it can be assumed that the deposition rate for nails and hair can be 
similar. Cappelle et al. [109] recently published a study where they investigated hair and nail 
samples from patients in drug withdrawal therapy. In accordance with the presented work, the 
authors found higher cocaine concentrations in hair than in the nails and higher concentrations for 
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its hydroxylated metabolite benzoylecgonine in the nails compared to hair. Both findings led to a 
higher benzoylecgonine/cocaine ratio in hair. While in the presented work it was discussed that 
this finding is related to a possible heat-driven hydrolysis during grinding of the samples, Cappelle 
et al. [109] raised the idea that the lack of melanin in the nails leads to a lower accumulation of 
cocaine. The detection of heroin in only a single nail segment and not in the other nail and hair 
segments may be an indication of phased incorporation into the nail.  
Unfortunately, due to the small number of cases and available evidence material, no comparisons 
between finger and toenail concentrations could be made in both studies. However, toenails 
should be less restricted by cosmetic influences. A study by Engelhart et al. [110] showed that the 
substance concentrations of finger and toenails differ. In addition, a comparison of the substance 
concentrations in the nail with those in a washing liquid showed similar conditions in fingernails 
and toenails. It was therefore assumed that the influence of external contamination on the nails in 
this study was rather small.  
An important analytical aspect became clear from the sample preparation. In both investigations 
the hair samples were ground in a ball mill in the same way as nail samples. In routine 
investigations for drugs of abuse, the hairs are usually cut into small pieces while for EtG the hair 
samples are milled. For one of the presented cases it could be shown that a loss of substance for 
hydrolysis-sensitive substances such as 6-acetylmorphin, cocaine or benzoylecgonine can be 
observed when grinding the hair. This was already pointed out by Pragst et al. [1]. To circumvent 
this problem, cooled ball mills may be better suited, or the samples may be frozen before 
processing. Since both matrices, hair and nails, were ground, this effect is included in both 
investigations, therefore the concentrations obtained remain comparable.  
In summary, this thesis, with its investigations, methods used and critical discussions, is in line 
with current research and makes an important contribution to retrospective studies of psychotropic 
drugs. It provides many other researchers with a quick overview of the current data and research 
situation regarding the detection of psychotropic drugs in hair and has made a very important effort 
to expanding the database of psychotropic drugs in hair by means of a larger statistical case 
numbers. For some substances even high two-digit to three-digit case numbers could be 
presented. This high number of cases, only rarely achieved in other studies, provides a great 
statistical certainty. In the introduction to this work, several situations from the everyday life of a 
forensic toxicologist were outlined. With the help of the collected data, these situations can now 
be dealt with in a much more profound way. Clearly, the data and critical discussion of the 
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interpretation of such results can meaningfully help other toxicologists with their own forensic 
investigations. The comparative studies of hair and nails made important contributions to basic 
research in this field, especially regarding concentration differences, sample extraction and 





















The present work importantly contributes valuable data to extend the detection of psychotropic 
drugs in hair. However, the lack of comparable data still exists and the research in the coming 
years should make efforts to overcome this situation. The chosen approach of the investigation of 
post-mortem cases with known psychotropic drug intake has led to the presentation of 
comprehensive data. The comparison with recently published data showed highly similar results 
despite different contexts of the hair samples. Thus, the collected data may be an important aid 
for forensic toxicologists, facilitate their daily work, and support them in interpreting concentrations 
of psychotropic drugs in hair. Nevertheless, the lack of certainty regarding the history and 
frequency of use remains a limitation of this approach. Although major hurdles are involved, 
controlled retrospective studies with comparable hair lengths and known dosages may help to 
overcome this uncertainty. With the developed and established LC-QQQ-MS method it is now 
possible to conduct retrospective clinical studies with controlled dosage in co-operation with 
psychiatric institutions. Through these types of studies, more profound data on psychotropic drugs 
in hair will be obtained, which will provide valuable assistance in interpreting the results of hair 
analyses. Since in previous publications contradictory results have been found regarding the 
correlation of dose and hair concentration [111], such studies are very valuable to investigate to 
what extent the ingested dose and concentration in hair can perhaps be correlated at some point 
in time by new techniques or statistical models. Once such correlations at some point will be well-
founded and scientifically accepted, they will certainly offer an exciting and above all non-invasive 
alternative to blood level determinations in the context of adherence controls. 
A study on living individuals with known drug intake was proposed and approved by the ethics 
committee. Recently, a co-operation with the Clinic for Psychiatrics and Psychology of the Charité 
University Medicine Berlin was initiated and is currently recruiting patients with a stable and long 
intake of antidepressants or antipsychotics. The foundation stone for further research work has 
thus been laid. 
Measurement results of hair analyses can vary to a certain extent depending on the extraction, 
decontamination and measurement technique used. The quality of such detection methods is 
proven on the one hand by validation and on the other hand by comparative proficiency testing. 
These are more important for hair analyses, since control samples used in routine analysis cannot 
completely mimic hair material into which substances have been naturally incorporated. Even if 
currently hair analysis for the detection of psychotropic drugs is rather rarely applied, it will be 
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important in the future to establish proficiency tests that address the analysis of psychotropic drugs 
in hair. To date, such proficiency tests are not commercially available. Alternatively, laboratory 
comparisons could be carried out using samples from controlled dose studies. However, due to 
the voluntary nature of the participation in such studies, cosmetic compatibility should be 
considered when taking samples, so that no large sample quantities could be obtained. Thus, only 
a few laboratories could participate in a comparison. These two testing options would drastically 
increase the comparability of methods and results from different laboratories and thus contribute 
to overall evaluation of measurement certainty. 
The investigation of the prevalence of certain psychotropic drugs in suicides and the 
comprehensive presentation of toxicological data may continue to represent a complementary 
approach to the risk assessment of these substances. It would be desirable to collect such data 
nationwide, as is the case in Sweden, for example. The accredited toxicological center in 
Linkoping investigated all post-mortem cases of Sweden and data is collected at a national health 
register for research purposes [112, 113]. This approach allows for more comprehensive statistical 
studies that are not limited to regional districts. However, the federal structure of Germany with its 
division into independent forensic institutes and the resulting great effort of a comprehensive 
exchange of data is currently an obstacle. 
A segmentation of whole nails and the comparative examination of nail segments with hair 
segments has not yet been reported by other research groups for drugs of abuse. Further of such, 
admittedly very costly, investigations would be necessary to confirm the results obtained from 
other sources. Although nails have been researched to some extent in recent years, there have 
been few controlled dose studies of individual substances. Research in this area should continue 
under controlled conditions in a similar approach to that for hair. Capelle et al. [114] point out that 
the relationship between the concentration in the nail and the concentration in other matrices (e.g. 
blood, urine, hair) should be brought more into focus. From an analytical point of view, efforts 
should be made to harmonize sample preparation, as this work also showed a strong influence of 
the preparation (grinding vs. cutting). Furthermore, proficiency tests for nails should be developed 
to ensure a comparable analytical quality [114]. In addition, extensive controlled studies should 
be carried out in the next years to establish cut-off values [114]. Some authors already proposed 
cut-off values for the detection of EtG in nails on the basis of small collectives [97, 106]. However, 
they all point out, that more the major problem for nail analysis is the lack of research that must 
be continued in the future. 
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Both presented nail studies in this work were preliminary investigations on very small case 
numbers and only few data on psychotropic drugs in the nail was found. Nevertheless, some 
important quantitative data were obtained for some substances. With the help of the validated 
methods now available, more extensive, at best comparative controlled dose studies should be 
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7 Summary 
Psychotropic drugs are a class of substances that are widely used in Germany and worldwide in 
the treatment of mental disorder and are therefore frequently prescribed. Like any drug, they have 
a certain side-effect profile, mainly comprising of cardiac and sedative components. Some of these 
substances, such as the tricyclic antidepressants, also have a high toxicity in case of overdoses. 
Due to these properties, the broad prescription and their toxicity, these substances may occur in 
different scenarios of forensic toxicological work. Their sedative properties and easy availability 
also make them substances that could potentially be used in crimes. To a certain extent, with the 
analysis of nails and hair it is possible to draw conclusions about the past frequency of use. The 
main objective of this thesis was to collect and meaningfully expand the currently available data 
on the detection of psychotropic drugs in hair in order to allow a comprehensive interpretation of 
such findings in daily forensic work. Furthermore, comparative studies of hair and nails should 
provide a deeper insight into the incorporation of substances in the nail and their use as an 
alternative matrix to hair. 
A comprehensive literature review showed that there are clear gaps in research on psychotropic 
drugs in hair, especially quantitative data. Three categories of publications were found: (i) method 
validations for the detection of numerous substances in hair, (ii) case reports and (iii) controlled 
dose administration studies. In the first two categories, often only small case numbers, very 
variable hair lengths and only very rarely information on the dosage taken was available. This was 
not the case in the controlled dose studies, which showed comparable hair lengths, at reported 
doses and assumed compliance. Furthermore, it was shown that the data basis for some, rather 
older, substances (e.g. amitriptyline) is very extensive through controlled dose studies, while many 
newer, now much more frequently prescribed substances (e.g. mirtazapine) were investigated in 
only a few studies. The publications also showed large differences in the sample preparation and 
extraction method selected. So far, no interlaboratory tests for psychotropic drugs in hair are 
available. For future studies a harmonization of the hair lengths and extraction methods used 
would therefore be welcome.   
In order to expand the data situation for psychotropic drugs in hair, two retrospective studies were 
conducted on post-mortem cases. For the identification of cases with known psychotropic drug 
ingestion, the toxicological test results of all deaths from 2012-2015 were evaluated in the section 
property of the Institute for Forensic Medicine of the Charité University Medicine Berlin. All cases 
with positive findings for a selected number of psychotropic drugs in blood, urine or tissue samples 
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were included, as these findings indicate acute or subacute influence at the time of death. 
Furthermore, the blood alcohol test was also evaluated in all cases. In these cases, it was 
assumed that they have taken psychotropic drugs for a longer period before sampling. It quickly 
became apparent that many of the cases with positive psychotropic drug evidence at death were 
suicides. From this observation, as well as from case reports [94] that found an increased risk of 
suicide under psychotropic drug use, the idea of conducting a comparative observational study 
was born. All included cases were divided into suicides (n=235) and non-suicides (n=212) on the 
basis of the final public prosecutor's investigations. In the group of suicides, higher frequencies 
were found for all substance classes compared to the group of non-suicides. The most frequently 
detected class of substances in the suicide group were TCAs, followed by SSRIs, ATYPs, TYPs, 
TECA and other substances. Among the individual substances, doxepin (20%), citalopram 
(15.3%), mirtazapine (14.9%), quetiapine (13.6%) and amitriptyline (12.3%) were detected most 
frequently. Alcohol was detected in about one third of the suicides compared to one fifth in the 
non-suicide group, in line with data from other authors [104-106]. This first study served to identify 
cases for further hair analysis with known ingestion of psychotropic drugs in the time before death. 
The next investigation dealt in the first step with the development and validation of a sensitive 
LC-QQQ-MS method to determine psychotropic drugs in hair. Based on the current prescription 
report of the health insurance companies for psychotropic drugs [13], 52 relevant substances were 
included in the method. The method was successfully validated based on the guidelines of the 
GTFCh for the validation of analytical methods [15, 73] for most analytes in a working range of 
0.005 - 2.5 ng/mg in hair. All validation requirements were tested and met. The range of the limits 
of quantification was very sensitive with 1.2 - 37 pg/mg in hair. Hair samples (n = 442) from the 
cases of the study on the frequency of antidepressants and antipsychotics in suicide together with 
cases in which psychotropic drug use was indicated in the public prosecutor's investigation file 
were examined in this study. A special feature of the study was the segmentation of the hair 
whenever possible. In those cases where segmentation was not possible due to the quality of the 
sample, the entire length of the hair was examined. In summary, quantitative data in hair were 
determined for 41 substances and 8 associated metabolites using n = 420 samples. The hair 
samples of twenty-two included cases were negative. In order to present the variations in the hair 
lengths, investigated population and the missing dose information in a statistically representable 
way, the quantitative data was presented in percentiles. With results of the previous study it was 
also possible to show that the detection in hair did not always correspond to the results in blood, 
urine or organs. Similar to the previous study, it was shown that in many cases more than one 
substance was often detected. The study further addressed the influence of external 
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contamination in postmortem hair analysis and its proposed interpretation based on the results of 
four cases. Taking into account the discussed limitations of the study, this work made an important 
contribution to the expansion of the data situation for psychotropic drugs in hair based on case 
numbers, some of which are in the three-digit range.  
In two comprehensive studies comparing hair and nails, valuable information was obtained on the 
incorporation of substances into the nail and the applicability of nail analysis in postmortem cases. 
After successful development validation of an LC-QQQ-MS method for the detection of EtG in 
nails and hair according to GTFCh guidelines [15, 73], fingernail edges and hair samples from 
living subjects with normal drinking behavior (n = 18) and from postmortem cases with chronically 
excessive drinking behaviour (n = 19) were examined. In agreement with other authors [113, 120], 
it was shown that the concentrations in the nail margin were higher than in hair. The different 
detection windows and a strong deposition of EtG via sweat in the nail margin were discussed as 
possible reasons for this. On the basis of four abstinent volunteers it was shown that nails are also 
suitable for abstinence control. In the postmortem cases, significantly different results were 
obtained between hair and nails. This observation was also confirmed in a further study, which 
dealt with a comparative segmental examination of nail and hair samples of selected postmortem 
cases. Two LC-QQQ-MS methods for the detection of 76 narcotics and psychotropic drugs in nails 
and hair were developed and validated according to GTFCh guidelines [15, 73]. Hair and nail 
samples from seven selected postmortem cases with known drug abuse in the past were 
examined and both hair and nail samples were comprehensively segmented. Similar to the results 
for the alcohol marker EtG, significantly different concentrations of narcotics were found in nails 
and hair. Additionally, the metabolite ratios for some substances were examined. It was found that 
some of the ratios of MDA/MDMA, EDDP/methadone and bisnortilidine/nortilidine were similar in 
hair and nails. Higher cocaine values in hair compared to nails and higher benzoylecgonine values 
in nails compared to hair were evident. Furthermore, quantitative data for four antidepressants 
(doxepin, trimipramine, mirtazapine, opipramol) and methylphenidate in nails and hair was 
presented.  
In summary, an important collection and extensive expansion of the data basis for numerous 
psychotropic drugs in hair was realized within the scope of this dissertation. This basis can be of 
decisive importance for daily forensic work and can serve as an important support for the 
interpretation of hair findings. The thesis also demonstrated that nails as alternative examination 
matrix to hair are in principle suitable within certain limitations and should remain the subject of 
further research. 




Psychopharmaka sind eine Klasse von Substanzen, die national und weltweit eine breite 
Anwendung in der Behandlung mentaler Erkrankungen finden und dementsprechend häufig 
verschrieben werden. Wie jedes Arzneimittel besitzen sie ein gewisses Nebenwirkungsprofil, 
welches hauptsächlich herzwirksame und sedierende Komponenten umfasst. Einige dieser 
Substanzen, wie etwa die trizyklischen Antidepressiva, weisen zudem eine hohe Toxizität bei 
Überdosierungen auf. Aufgrund dieser Eigenschaften, der breiten Verschreibung und ihrer 
Toxizität können diese Substanzen in verschiedenen Szenarien von forensisch toxikologischer 
Arbeit vorkommen. Die sedierenden Eigenschaften und leichte Verfügbarkeit machen sie zudem 
zu Substanzen, die potenziell in Verbrechen eingesetzt werden können. Bis zu einem gewissen 
Grad ist es mit der Analyse von Nägeln und Haaren möglich, Rückschlüsse auf die zurückliegende 
Einnahmehäufigkeit zu ziehen. Das Hauptziel dieser Arbeit war es, die derzeit verfügbaren Daten 
über den Nachweis von Psychopharmaka im Haar zu sammeln und sinnvoll zu erweitern, um eine 
umfassende Interpretation solcher Befunde in der täglichen forensischen Arbeit zu ermöglichen. 
Weiterhin sollten vergleichende Untersuchungen von Haaren und Nägeln einen tieferen Einblick 
in die Einlagerung von Substanzen in den Nagel und die Verwendung als alternative Matrix zu 
Haaren geben.  
Eine umfassende Literaturstudie zeigte, dass die Forschung zu Psychopharmaka im Haar, im 
speziellen zu quantitativen Daten, deutliche Lücken aufweist. Die verfügbaren Veröffentlichungen 
gliederten sich grob in drei Kategorien: (i) Methodenvalidierungen für den Nachweis von 
zahlreichen Substanzen im Haar, (ii) Fallberichte und (iii) kontrollierte Dosisstudien. In den ersten 
beiden Kategorien lagen oftmals nur kleine Fallzahlen sowie sehr variierende Haarlängen vor und 
nur äußerst selten wurden Informationen zur eingenommenen Dosierung angegeben. Dies traf 
auf die kontrollierten Dosisstudien nicht zu, die vergleichbare Haarlängen und bekannte 
Dosierungen bei angenommener Compliance vorwiesen. Weiterhin zeigte sich, dass die 
Datengrundlage für einige, eher ältere, Substanzen (z.B. Amitriptylin) durch kontrollierte 
Dosisstudien sehr umfangreich ist, während viele neuere, heute wesentlich häufiger 
verschriebene Substanzen (z.B. Mirtazapin) in nur wenigen Studien untersucht wurden. Die 
Veröffentlichungen zeigten auch große Unterschiede bei der gewählten Probenaufarbeitung und 
Extraktion. Bisher sind keine Ringversuche für Psychopharmaka im Haar verfügbar. Für 
zukünftige Studien ist daher eine Harmonisierung der verwendeten Haarlängen und 
Extraktionsverfahren erforderlich und wünschenswert.   
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Zur Erweiterung der Datenlage für Psychopharmaka im Haar wurden daher zwei retrospektive 
Untersuchungen im Rahmen von Sterbefällen durchgeführt. Zur Identifizierung von Fällen mit 
bekannter Psychopharmaka-Einnahme wurden im Sektionsgut des Instituts für Rechtsmedizin der 
Charité - Universitätsmedizin Berlin die toxikologischen Testergebnisse aller Todesfälle der Jahre 
2012-2015 ausgewertet. Alle Fälle mit positivem Befund für eine ausgewählte Anzahl von 
Psychopharmaka im Blut, Urin oder Gewebeproben wurden einbezogen, da diese Befunde auf 
einen akuten oder subakuten Einfluss zum Todeszeitpunkt hinweisen. Bei diesen Fällen wurde 
angenommen, dass sie auch längere Zeit vor der Probenahme Psychopharmaka eingenommen 
haben könnten. Dabei zeigte sich sehr schnell, dass es sich bei vielen der Fälle mit positivem 
Psychopharmaka-Nachweis zum Zeitpunkt des Todeseintritts um Suizide handelte. Aus dieser 
Beobachtung heraus, sowie aus Fallberichten [94], die ein erhöhtes Suizidrisiko unter 
Psychopharmaka-Einnahme feststellten, entstand die Idee eine vergleichende 
Beobachtungsstudie durchzuführen. Alle eingeschlossenen Fälle wurden anhand der 
abschließenden staatsanwaltschaftlichen Ermittlungen in Suizide (n=235) und Nicht-Suizide 
(n=212) eingeteilt. In der Gruppe der Suizide zeigten sich für alle Substanzklassen höhere 
Häufigkeiten im Vergleich zur Gruppe der Nicht-Suizide. Die am häufigsten nachgewiesene 
Klasse von Substanzen in der Gruppe der Suizide waren trizyklische Antidepressiva (TCA), 
gefolgt von selektiven Serotonin-Reuptake Inhibitoren (SSRI), atypischen Neuroleptika (ATYP), 
typischen Neuroleptika (TYP), tetrazyklischen Antidepressiva (TECA) und weiteren Substanzen. 
Unter den einzelnen Substanzen wurden Doxepin (20 %), Citalopram (15,3 %), Mirtazapin (14.9 
%), Quetiapin (13.6 %) und Amitriptylin (12.3 %) am häufigsten detektiert. Alkohol wurde in 
Übereinstimmung mit Daten anderer Autoren [104-106] in ca. einem Drittel der Suizide im 
Vergleich zu einem Fünftel in der Gruppe der Nicht-Suizide nachgewiesen. Diese erste Studie 
diente dazu, Fälle für weitere Haaranalysen mit bekannter Einnahme von Psychopharmaka in der 
Zeit vor dem Tod zu identifizieren. 
Die nächste Untersuchung befasste sich im ersten Schritt mit der Entwicklung und Validierung 
einer LC-QQQ-MS-Methode zur Bestimmung von Psychopharmaka im Haar. Auf der Grundlage 
des aktuellen Verschreibungsreports der Krankenkassen für Psychopharmaka [13] wurden 52 
relevante Substanzen in die Methode aufgenommen. Die Methode wurde auf der Basis der 
Richtlinien der GTFCh [15, 73] für die Validierung von Analysenmethoden für die meisten Analyte 
in einem Konzentrationsbereich von 0.005 - 2.5 ng/mg im Haar erfolgreich validiert. Alle 
Anforderungen an die Validierung wurden getestet und erfüllt. Die Bestimmungsgrenzen waren 
mit 1.2 - 37 pg/mg im Haar sehr niedrig. In dieser Studie wurden Haarproben (n = 442) von in der 
Studie über die Häufigkeit von Antidepressiva und Antipsychotika bei Suiziden identifizierten 
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Fällen zusammen mit Fällen untersucht, in denen in der Ermittlungsakte der Staatsanwaltschaft 
auf psychotropen Drogenkonsum hingewiesen wurde. Eine Besonderheit der Untersuchung war 
die Segmentierung der Haare, wann immer dies möglich war. In den Fällen, in denen keine 
Segmentierung aufgrund der Qualität der Probe möglich war, wurde jeweils die gesamte 
Haarlänge untersucht. Zusammengefasst wurden quantitative Daten im Haar für 41 Substanzen 
und 8 zugehörigen Metaboliten anhand von n=420 Proben ermittelt. Die Haarproben von 
zweiundzwanzig eingeschlossenen Fällen waren negativ. Um die Variationen in den Haarlängen, 
der untersuchten Population und die fehlenden Dosisinformationen statistisch darzustellen, 
wurden die quantitativen Daten in Perzentilen ausgewertet. Dies bildet einerseits die Unterschiede 
bezüglich der verwendeten Haarlängen, aber auch die Variationen innerhalb der untersuchten 
Zwecke und Populationen gut ab. Anhand der Ergebnisse der vorherigen Studie konnte auch 
gezeigt werden, dass der Nachweis in den Haaren nicht immer mit den Ergebnissen in Blut, Urin 
oder Organen übereinstimmte. Ähnlich wie in der Vorgängerstudie konnte gezeigt werden, dass 
in vielen Fällen oft mehr als eine Substanz nachgewiesen wurde.  Ähnlich der zuvor 
durchgeführten Studie, zeigte sich, dass in vielen Fällen häufig mehr als eine Substanz 
nachgewiesen wurde. Die Studie befasste sich ferner mit dem Einfluss der äußeren Kontamination 
bei der postmortalen Haaranalyse und ihrer vorgeschlagenen Interpretation auf der Grundlage 
der Ergebnisse von vier Fällen. Unter Berücksichtigung der diskutierten Einschränkungen der 
Studie leistete diese Arbeit einen wichtigen Beitrag zur Erweiterung der Datenlage für 
Psychopharmaka im Haar auf der Basis von Fallzahlen, die zum Teil im dreistelligen Bereich 
liegen. Mit Hilfe dieser Daten wird die Interpretation von Psychopharmaka-Befunden im Haar 
wesentlich erleichtert und in konkreten Fragestellungen unterstützt. 
In zwei umfassenden Studien zum Vergleich von Haaren und Nägeln wurden wertvolle 
Informationen über die Einarbeitung von Substanzen in den Nagel und die Anwendbarkeit der 
Nagelanalyse in postmortalen Fällen gewonnen. Nach erfolgreicher Validierung einer LC-QQQ-
MS-Methode zum Nachweis von EtG in Nägeln und Haaren nach den Richtlinien der GTFCh [15, 
73] wurden Fingernagelränder und Haarproben von lebenden Probanden mit normalem 
Trinkverhalten (n = 18) und von postmortalen Fällen mit chronisch übermäßigem Trinkverhalten 
(n = 19) untersucht. In Übereinstimmung mit anderen Autoren [113, 120] zeigte sich, dass die 
Konzentrationen im Nagelrand höher waren als in den in Haaren. Als möglicher Grund wurden 
dafür die unterschiedlichen Nachweisfenster und eine erhöhte Einlagerung des EtG über den 
Schweiß in den Nagelrand diskutiert. Anhand von vier abstinent lebenden Probanden konnte 
gezeigt werden, dass sich Nägel auch für eine Abstinenzkontrolle eignen. Bei den Sterbefällen 
zeigten sich deutlich unterschiedlichere Ergebnisse zwischen Haaren und Nägeln. Diese 
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Beobachtung wurde auch in einer weiteren Studie bestätigt, die sich mit einer vergleichenden und 
segmentweisen Untersuchung von Nagel- und Haarproben ausgewählter postmortem Fälle 
befasste. Zwei LC-QQQ-MS-Methoden zum Nachweis von 76 Betäubungsmitteln und 
Psychopharmaka in Nägeln und Haaren entwickelt und nach den Richtlinien der GTFCh [15, 73] 
validiert. Haar- und Nagelproben von sieben ausgewählten postmortalen Fällen mit bekanntem 
Drogenmissbrauch in der Vergangenheit wurden untersucht und sowohl Haar- als auch 
Nagelproben umfassend segmentiert. Ähnlich den Ergebnissen für den Alkoholmarker EtG 
zeigten sich deutlich unterschiedliche Konzentrationen für Betäubungsmittel in Nägeln und 
Haaren. Zusätzlich wurden für einige Substanzen die Metabolitenverhältnisse untersucht. Es 
wurde festgestellt, dass einige der Verhältnisse von MDA/MDMA, EDDP/Methadon und 
Bisnortilidin/Nortilidin bei Haar und Nägeln ähnlich waren. Es wurden höhere Kokainwerte im Haar 
im Vergleich zu den Nägeln und höhere Benzoylecgonin-Werte in den Nägeln im Vergleich zu den 
Haaren. Darüber hinaus wurden quantitative Daten für vier Antidepressiva (Doxepin, Trimipramin, 
Mirtazapin, Opipramol) und Methylphenidat in Nägeln und Haaren vorgelegt. 
Zusammengefasst wurde im Rahmen dieser Dissertation eine wichtige Erfassung und 
umfangreiche Erweiterung der Datengrundlage für zahlreiche Psychopharmaka im Haar realisiert. 
Diese Grundlage kann für die tägliche forensische Arbeit von entscheidender Bedeutung sein und 
als wichtige Stütze für die Interpretation von Haarbefunden dienen. Weiterhin wurde dieser Arbeit 
gezeigt, dass sich Nägel als alternative Untersuchungsmatrix zu Haaren prinzipiell (mit 
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